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Abstract
Candida albicans is a human fungal commensal and an opportunistic pathogen. It
is a polymorphic fungus that is able to invade host cells and disseminate through tissues.
C. albicans also form biofilms on medical devices and mucosal surfaces, which aid in the
development of drug resistance, tissue colonization and evasion of host immunity.
Disseminated candidiasis is associated with high mortality rates, especially in
immunocompromised hosts. Concern about resistance to current antifungal therapies has
led to a push to develop novel, alternative treatments. In this study, we investigated the
antifungal activities of two agents: PPE-DABCO, a poly(phenylene ethynylene) (PPE)based cationic conjugated polyelectrolyte (CPE), and EO-OPE-1 (DABCO), an oligophenylene ethynylene (OPE). Both compounds generate singlet oxygen upon UVirradiation. The effect of both compounds against C. albicans was tested in the dark and
with photoactivation using light of the appropriate wavelength for each agent. We
demonstrated that both compounds showed enhanced antifungal activity when irradiated
with UV-light, reducing the viability of yeast in suspension. Activation of PPE-DABCO
with the 405nm confocal laser was also able to significantly reduce the viability of C.
albicans yeast and hyphal cells. Furthermore, by limiting the time of exposure to the
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405nm laser to 20 minutes, we were able to isolate the effects of photoactivation of PPEDABCO from effects due to phototoxicity, by assessing the subsequent hyphal growth.
Neither dark nor light treatment with either compound was able to prevent the biofilm
formation of surviving cells. This study provides evidence that PPE-DABCO and EODABCO act as potent antifungal agents upon photoactivation, and photoactivation is
necessary to achieve full antifungal efficacy to reduce the viability of yeast and hyphae
and prevent morphological transitioning.
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Chapter 1. Introduction
1.1 Candida albicans: a human fungal commensal and opportunistic pathogen
Candida albicans is a human fungal commensal that commonly colonizes
mucosal surfaces and is found as part of the normal flora in greater than half of the
population. It is also an opportunistic human pathogen; displaying a pattern of
invasiveness into tissues and the bloodstream stemming from an abnormal overgrowth in
urinary, gastrointestinal, and respiratory tracts. While this infection is frequently
observed in immunocompromised patients, it is becoming increasingly common in
healthy individuals as a result of nosocomial infections. (1). Candida spp. provides a
significant contribution to morbidity and mortality rates; candidemia is associated with
mortality rates that are reported as 30-40% (2). Of the Candida spp., C. albicans is the
most prevalent pathogen identified as the cause of nosocomial infections, greater than
50% (3). The risk factors for acquiring candidiasis includes surgery, often involving the
use

of

implanted

catheters

or

other

medical

devices,

administration

of

immunosuppressive medications, previous use of broad-spectrum antibiotics, or wounds
such as burns or skin abrasions (4). Clinical treatment of invasive candidiasis using
current antifungals is complicated by resistance to these drugs, either acquired or
intrinsic, which contributes to an increase in morbidity, mortality, cost of treatments and
duration of hospitalization (5). The pathogenicity of C. albicans is mediated by a wide
range of virulence factors that enable the infection of a number of host niches. Some of
these factors include the ability to switch between morphological forms, the expression of
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adhesins and invasins, biofilm formation, thigmotropism, and the secretion of hydrolytic
enzymes to degrade host tissue and promote invasion (6).
1.2 Yeast to hyphal morphological transition
C.albicans is polymorphic and can grow as yeast, which are spherical or ovoid in
shape and reproduce by budding, pseudohypae, which are ellipsoid-shaped, elongated
yeast cells that remain attached to other cells at a defined and constricted site of
separation, or as hyphae, the filamentous form of the cells, that have sides that remain
parallel along the entire length, and have a tube-like morphology. The switch to hyphal
form is regulated by a series of signal transduction cascades that are initiated by
numerous environmental factors, such as changes in temperature and pH, limiting
nitrogen and carbon in the environment, and the presence of human hormones, such as
progesterone, oestrogen, luteinizing hormone (LH) and human chorionic gonadotrophim
(hCG) (7, 8, 9). Several transcription factors are activated in this process, including
Cph1p and Efg1p, which are targets of the mitogen-activated protein kinase (MAPK)
pathway, and the Ras-cAMP pathway, respectively (7, 10). These transcription factors
are essential to activation of genes necessary for hyphal development, including HWP1,
which encodes a GPI-linked cell surface protein that is expressed exclusively in hyphal
cells. HWP1 expression is dependent upon Efg1p (10). Deletion of either Efg1p or
Cph1p, results in a defect in hyphal formation in response to an elevation in temperature
to 37◦C and addition of serum, environmental triggers that induce hyphal growth in wildtype cells (11).
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This ability to switch between morphological forms is associated with virulence
(12). The hyphal form is associated with tissue invasion, due in part environmental
factors within the host organism that promote the switch to this morphology, including
temperature and pH. Furthermore, it has been found that C. albicans isolates that are
defective in forming hyphae are associated with a decrease in the virulence of the
pathogen (13). A study by Lo et al. demonstrated that a mutant strain of C. albicans,
defective in the expression of two genes that are necessary for induction of filamentation,
were avirulent in a mouse model (14). However, there is supporting evidence that the
ability to switch between morphological forms is a major factor predicting virulence in C.
albicans isolates. In fact, both yeast and hyphae have been found to be present in infected
organs, and the predominance of one form or another depends largely upon the organ that
is being infected (15, 16).
1.3 Biofilm formation by C. albicans
The ability of C. albicans to form robust biofilm structures contributes to the
ability of the cells to survive adverse environmental conditions. The transition to hyphal
form is not necessary for the formation of a biofilm structure; in fact, biofilms formed
from C. albicans mutants defective in producing hyphae retain the ability to form dense
three-dimensional structures that display similar resistance to amphotericin B (17).
Biofilms are characterized as a three-dimensional structural community of
microorganisms that are embedded in copious amounts of extracellular matrix. These
structures become sessile upon attachment to a surface, which is the primary stage of
biofilm development (18). In the case of C. albicans biofilms, the formation of the
structures can be defined in a series of distinct phases. The first phase, attachment to a
3

surface, involves cells, usually in the form of yeast, adhering to a surface. Once adhered,
the cells begin to enter the second stage of biofilm development, which is typified by
cellular proliferation resulting in the formation of microcolonies. The third stage involves
the expansion of the microcolonies to form a complex three-dimensional structure.
During this stage, the cells begin to grow and produce hyphae, which are an alternative
filamentous morphological form of C. albicans, and secrete extracellular matrix (ECM), a
heterogenous composition of proteins, nucleic acids, carbohydrates and other materials
produced or shed by the growing cells (17). The presence of extracellular DNA and other
nucleic acids in the ECM is not a unique feature to C. albicans biofilm structure, but
there is evidence that it may play a role in the ongoing maintenance and stability of
mature biofilms, as well as the induction of the yeast to hyphal transition during biofilm
development (19, 25). C. albicans biofilms can be diverse in structural form and cellular
composition, with the surface to which initial adhesion occurs being a major influence on
these characteristics.
1.4 C. albicans biofilm resistance to antifungals
Biofilms are particularly resistant to antimicrobial compounds. A study by
Chandra et al. provided evidence that the MICs for amphotericin B, fluconazole, nystatin,
and chlorhexidine all increased progressively as C. albicans biofilms matured (20). The
complexity of biofilm structure and the heterogeneity of biofilm composition create
multiple mechanisms for antimicrobial resistance. This is further evidenced by the
observation, by our lab, that biofilm development is characterized by heterogeneous cell
populations that display discrete growth rates, both in the presence and absence of subMIC concentrations of clinically used antifungal drugs. Furthermore, there is evidence
4

that the presence of persister cells within a biofilm, which are characterized as cells
possessing a variant phenotype that confers antimicrobial resistance, possess the ability to
produce new resistant biofilm structures following drug treatment (21). Cell growth
within biofilms, characterized by both increasing cellular mass, formation of three
dimensional structural complexity, and increased metabolic rate, may contribute to the
resistance of biofilms to known antifungals, but cannot account for it completely (22). A
study conducted by Baillie et al., dispelled the idea that the biofilm growth rate of C.
albicans alone conferred resistance to the common antifungal amphotericin B (23).
Maturing biofilms also produce copious quantities of extracellular matrix, which
is a heterogenous material consisting of carbohydrates, nucleic acids, proteins,
phosphorous and other materials produced by the cells; this material may vary in relative
abundance of the individual components based upon factors such as maturity of the
biofilm or morphological form of the secreting cells (24). Extracellular matrix production
may contribute to the resistance of C. albicans biofilms to antimicrobial compounds by
acting as a diffusion barrier, preventing access of the drugs to cells embedded deep
within the biofilm structure. However, there is evidence that suggests that the
extracellular matrix produced by C. albicans biofilms does not prevent fully the
penetration of several common antifungal drugs (24). Extracellular DNA (eDNA) in the
ECM has been linked to increased resistance to several clinically used antifungals, and
has been demonstrated to play a role in maintaining the integrity of mature C. albicans
biofilm structures. A study by Martins et al. provided evidence that increasing biofilm
biomass can be linked to an increase in the eDNA content in the ECM, and biofilm mass
decreases upon addition of DNase treatment (25). There is also evidence that DNase
5

treatment increases the efficacy of amphotericin B against C. albicans biofilms, although
this form of combination therapy does not appear to increase the susceptibility of
biofilms to other antifungals, such as fluconazole (26).
C. albicans biofilms also have several molecular mechanisms by which
antimicrobial resistance is achieved, although this is an area requiring further
investigation. One such mechanism contributing to azole resistance is the expression of
ATP-binding cassette (ABC) transporters and the major facilitator superfamily (MFS)
transporters that actively efflux drugs, which contribute to resistance in both biofilms and
free-floating cells (27). A recent study using a clinical isolate of C. albicans from a
hospital in Tunisia, found that azole resistance in this isolate was due to the
overexpression of a multidrug efflux pump of the superfamily, Mdr1, due to a gain-offunction mutation (28). However, the presence of certain drug transporters in the cell
membrane alone may not confer resistance. A study conducted by Shah et al. found that
the absence of the Quinidine Drug Resistance (QDR) transporters in the cell membrane
did not increase the susceptibility of C. albicans to a number of cell wall stressors or
common antifungals, although these strains did show defects in both biofilm formation
and attenuated virulence (29). Other molecular mechanisms governing resistance in C.
albicans biofilms have been recently identified, such as the presence of heterozygousMTL (mating type locus) cells within a biofilm (a/α), which confers a far less permeable
environment for penetration of both antifungal agents and polymorphonuclear leukocytes
than biofilms comprised of cells that are homogeneous at this locus. As 90% of C.
albicans are of the heterozygous MTL variety, this type of biofilm is commonly found in
both nature and in clinical settings (30).
6

1.5 C. albicans mechanisms of adhesion to host cells
Adhesion is mediated by a family of large cell-surface glycoproteins encoded by
the agglutinin-like (ALS) genes, which are regulated differently according to whether the
cells are growing in planktonic or hyphal forms (20). Furthermore, these genes display
altered regulation due to medium changes or growth stages. The Als proteins are linked
to beta1,6-glucan within the cell wall, acting as a glycosylphosphatidylinositol (GPI)module, and are heavily N- and O-glycosylated (36). Also implicated in adhesion is
hyphal wall protein 1 (Hwp1), which contains an amino-terminal domain that is exposed
on the cell wall surface, and can cross-link with exogenous proteins (37). A study by
Younes et al. linked Hwp2 with contributing to tolerance to oxidative stress as well as
adhesion to human endothelial and epithelial cells, formation of biofilms and chitin
content of the cell wall. C. albicans strains that were deficient in Hwp2, were less
adherent to endothelial and epithelial cells, unable to form wild-type biofilm structures,
and more susceptible to oxidative stress by exogenous hydrogen peroxide (38). Other
factors influencing adhesion are the relative hydrophobicity of the cell wall, which may
influence adhesion to epithelial cells often influenced by the relative glycosylation of
mannoproteins within the cell wall (39).
1.6 C. albicans mechanisms of invasion into host cells
C. albicans possesses the ability to invade host tissues using two distinct
mechanisms: active penetration or induced endocytosis (6). The expression of invasins on
the fungal cell surface, proteins on the cell surface of the fungi that mediate binding to
host tissues, allow the pathogen to induce host cells to endocytose fungal cells (31). The
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two invasins that are implicated in this process are Als3 and Ssa1 (6). Als3, which also
functions as an adhesin, binds to E-cadherin on epithelial cells or N-cadherin on
endothelial cells to induce endocytosis, by activation of the clathrin-dependent
endocytosis pathway (32). Ssa1 is a member of the heat shock protein 70 (Hsp70) family
that is expressed on the cell surface; it can directly mediate adherence to and endocytosis
by host cells by the same mechanism as Als3 (33). Active penetration of C. albicans into
host tissues is a less well understood mechanism, but appears to require the hyphal
morphology of the pathogen, as well as both the adhesion of fungal cells to host tissues,
secretion of hydrolytic enzymes and the application of physical force (34). The
importance of hyphal formation in invasion is evidenced in a study by Felk et al. in
which a strain of C. albicans that lacked the expression of the transcription factor Efg1,
and could not form hyphae, was not able to invade or damage parenchymal organs in
mice (35).
1.7 Secretion of hydrolytic enzymes enhances C. albicans virulence
The ability of C. albicans to secrete hydrolases following adhesion to host cells is
an important virulence factor that is thought to both facilitate penetration into host
tissues, as well as increase the availability of extracellular nutrients, and digesting
components of the host immune system (34, 40). C. albicans produce three main types of
hydrolytic enzymes: secreted aspartyl proteinases (Sap), phospholipase B enzymes, and
lipases.
The Sap proteins are encoded by 10 SAP genes in C. albicans, although many
other pathogenic Candida species also possess some of these genes as well. Sap1-8 are
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secreted forms, while Sap9 and Sap10 are bound to the cell surface (6, 40). Sap proteins
are differentially expressed based upon environmental cues, such as pH or availability of
nitrogen sources, which may partially explain the ability of the pathogen to colonize
many different host tissues (41). Furthermore, Sap proteins are differentially expressed
depending upon the morphological form of the fungi; for example, SAP4 and SAP6
expression is associated with the transition to the hyphal form, while SAP1 may be
regulated by phenotypic switching (42, 41, 40). One of the proposed functions of Sap
proteins may be to mediate adherence to host cells (40). The relative level of Sap protein
expression may also predict virulence, as evidenced in a study by Felk et al. in which C.
albicans strains that were sufficient in hyphal formation, but lacked Sap proteins
associated with hyphal growth, particularity Sap6, were less invasive in a murine model
of disseminated candidiasis (43). Recently, there has been some evidence that Sap
production may play a role in inducing apoptosis in epithelial cells, by damaging
lysosomal membranes following internalization by epithelial cells (44).
The phospholipases are comprised of a group of enzymes that are able to
hydrolyze the ester bonds in phospholipids. The specificity of the ester bond that each
enzyme is able to cleave lead to the use of grouping and lettering the enzymes A, B, C,
and D, which indicate the target bond (45, 46). Phospholipase B (PLB) is the
predominant phospholipase in Candida, accounting for ~90% of the extracellular
phospholipase activity. PLB possesses both hydrolase and lysophospholipasetransacylase (LPTA) activities. The hydrolase activity of the enzyme results in the release
of fatty acids from phospholipids and lysophospholipids; the transacylase activity of PLB
results in the production of a phospholipid by transfer of a free fatty acid to a
9

lysophospholipid. This activity is thought to facilitate invasion of the pathogen by leading
to cell membrane disruption in host cells, which may cause cell lysis and promote
transmigration of the fungi (46).
C. albicans also secrete lipases during invasive growth, which enzymes are
capable of catalyzing both the hydrolysis and synthesis of triacylglycerols (47). C.
albicans possess 10 lipase genes; but differential expression of these genes has been
observed, which appears to be partially dependent upon the relative location of infection
(48). Lipase 8 has been associated with increased virulence in murine intravenous
infection models (47).
1.8 Cell wall composition of C. albicans
The cell wall of C. albicans that surrounds the cell provides two essential
functions; it protects the cell by providing a rigid structure that maintains cellular
integrity and interacts with the surrounding environment to provide cues to the cell that
helps ensure survival (50). Localized externally to the cell membrane of the fungi, it is
comprised of a multipart organized structure that primarily consists of beta-glucans (β1,3
and β1,6-glucan), which are complex glucose polymers (50).The beta-glucans form
around 50-60% of the cell wall structure and are largely responsible for providing the
structural rigidity that provides both cellular shape and protection (51, 49) The betaglucans are enriched in the inner portion of the cell wall. They contribute to a pliable
highly branched network of beta1,3-glucan that attaches to both chitin and beta-1,6glucan via the multiple reducing ends of the branched polymer (50). The reducing ends of
the beta-glucans also have a role in facilitating the attachment of multiple types of cell
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wall proteins (50), primarily glycosylphosphatidylinositol (GPI)-dependent and Pir cell
wall proteins (49). Soluble glucans are also shed by the fungal cell wall and can enter into
the blood stream of patients during active fungal infections, and are responsible for the
activation of a number of host immune responses (52). The second most abundant
components of the C. albicans cell wall are mannoproteins, which comprise about 3040% of the structure. They are mainly found in the outer layer of the cell wall, whereas
the inner cell wall layer consists mainly of the fibril network of glucan and chitin (53).
The mannoproteins mediate adherence of the cells to various surfaces, including tissues
of host organisms, as well as possessing a role in modulation of the immune response
within the host organism (50). Chitin is of relatively low abundance within the cell wall,
comprising a mere 0.6-3% of the structure, but is of utmost importance in the
maintenance of cell wall rigidity, primarily due to the interactions with the beta-glucan
network of fibrils (51). Increased chitin content within the cell wall can also allow the
integrity of the cell wall to be maintained in instances when the synthesis of beta1,3glucans is compromised, either because of mutations or defects in the synthesis pathway
caused by exposure to certain types of antifungal drugs, particularly echinocandins,
which inhibit the production of 1,3-beta-D-glucan by interference with the catalytic
subunit of Beta (1,3)-glucan synthase, Fks1 (54, 55). In addition to increasing chitin
content within the cell wall, C. albicans can achieve further structural stability by
increasing the linkages between chitin and beta1,6-glucans (49, 56, 57). Cell wall
proteins are a major factor influencing the composition of the cell wall. These proteins
are usually heavily O-mannosylated at both serine and threonine residues, which
facilitates convalent attachment of these proteins to the beta-1,6-glucan fibrils; without
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the O-mannosylation of these proteins, cells will undergo heavy cell wall remodeling by
upregulation of chitin and beta1,3-glucan (53). The modification of cell wall proteins
begins in the ER, due to the activity of five nonredundant isoforms of protein-Omannosyltransferases (Pmt1, Pmt2, Pmt4, Pmt5, Pmt6) prior to partial extension of the
O-mannosylation in the Golgi by mannosyltransferases (58). Defects in any of these
enzymes can lead to various negative consequences to the cell, including increased
antifungal sensitivity, changes in internal turgor pressure to combat weakening of the cell
wall, lowered virulence, and changes in the ability to form hyphae (59, 60 ,61).
The ability of C. albicans to undergo dynamic cell wall remodeling in response to
stress partially responsible for the robustness of this pathogenic fungi even in adverse
environments. One such mechanism by which C. albicans senses environmental stress
and compensates by undergoing cell wall remodeling is by activating the cell wall
integrity (CWI) pathway. Much of what is understood about this pathway has been
elucidated in studies involving S. cerevisiae. The CWI pathway is a kinase cascade that is
tightly regulated by a series of GTPase-activating proteins and guanyl nucleotide
exchange factors (GEFs); when this cascade is initiated, it leads to the activation of
transcription factors that lead to cell wall remodeling (62). Two cell wall-associated
stress sensors, Wsc1 and Mid2, initiate the cascade by binding to Rom2, which acts as a
GEF for Rho1 (63, 62, 64). Activation of Pkc1 by Rho1 begins the activation of the
MAPK cascade, ultimately ending in the phosphorylation of Rlm1 and SBF, two
transcription factors that stimulate the expression of genes necessary for cell wall
synthesis (65, 66, 62). SBF is a heterodimer comprised of two proteins Swi4 and Swi6,
and is of primary importance during the G1/S transition (67). The importance of Rlm1 in
12

cell wall biogenesis and maintenance is evidenced in a study by Delgado-Silva et al. in
which deletion of this transcription factor lead to significant cell wall remodeling,
including an increase in chitin and a concurrent reduction in mannans, and an increased
sensitivity to compounds associated with the induction of cell wall stress, including
calcofluor-white and caspofungin (68).
C.albicans also possesses a mechanism which allows yeast to respond to
additional osmotic stress known as the high-osmolarity glycerol (HOG) pathway (69).
This pathway may be activated by two different input branches. The first is the Sho1
branch, which responds to severe hyperosmotic stress using two plasma membrane
proteins, Sho1 and Msb2. Once initiated the Rho GTPase Cdc42 is activated, along with
Ste20 and Ste50. Ste20 activates the MAPKKK Ste11, which subsequently activates Pbs2
, which activates Hog1 (70, 69). The second branch also leads to Pbs2 activation, but
involves the transmembrane protein Sln1 and the regulatory response proteins Ypd1 and
Ssk1 (71). Once initiated, this pathway results in the activation of two redundant
MAPKKKs, Ssk2 and Ssk22, which activate Pbs2. Activation of Hog1 results in the
transcriptional activation of genes that are critical for the cellular response to osmotic
stress (67). Although the CWI pathway is the primary pathway that is involved in cell
wall construction, the Hog1 pathway is also activated under conditions of cell wall
damage, and both pathways are necessary for cell survival in these circumstances (67).
1.9 Current antifungal treatments for invasive candidiasis
Prior to the introduction of echinocandins, only three classes of antifungal drugs
have been clinically used to treat Candidiasis and other fungal infections: the polyenes
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(amphotericin B); the azoles (ketoconazole, itraconazole, fluconazole, and voriconazole);
and flucytosine (72). The use of these drugs clinically, as well as increasing reports of
resistance in clinical isolates, demonstrated a need for standardization of the techniques
used for antifungal susceptibility testing. The protocols for assessing susceptibility for
both yeast and filamentous fungi were established by the Clinical and Laboratory
Standards Institute in 2002 (73, 74). However, susceptibility testing results do not always
accurately predict the clinical responses to different antifungal therapies. This
observation in antibacterial susceptibility testing resulted in the implication of the “90-60
rule”, in which it is predicted that isolates deemed susceptible will respond to treatment
around 90% of the time, and isolates found to be resistant will respond to treatment
around 60% of the time (72). While the refinement of susceptibility testing is necessary,
this approximation is a clinically useful predictive tool that aids treatment of fungal
infections. However, increasing resistance to antifungals is a major clinical concern that
necessitates the development of new antifungal therapies that can be applied in a clinical
setting.
The antifungal class of azoles, which includes both the imidazoles and the
triazoles, combat fungal infections by preventing the biosynthesis of ergosterol through
inhibition of lanosterol 14-α-demethylase (75). Ergosterol is the main sterol component
of the fungal cell membrane, and is analogous to cholesterol in mammalian cells;
inhibition of the biosynthetic pathway causes ergosterol depletion in the membrane as
well as a toxic buildup of methylated sterol intermediates. Azoles act by targeting C14
lanosterol demethylase (76). This leads to growth inhibition of the cell, and in some
cases, cell death (77). However, there is considerable difficulty in successfully treating
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fungal biofilms with azoles, as biofilms show considerable resistance to these compounds
compared to the MICs used against planktonic cells; almost 1000 fold increase over the
MIC needed to kill cells in suspension was needed to inhibit C.albicans biofilms in one
study (78). Beta-1,3-glucan, present in the ECM of Candida biofilms, is implicated in
fluconazole resistance, by binding to and sequestering the drug before it has the
opportunity to diffuse to the cells located deep within the biofilm structure (79, 78). It has
been demonstrated that azoles have the ability to induce the accumulation of reactive
oxygen species (ROS) in planktonic cells, particularly miconazole. However, the ability
of these compounds to induce ROS accumulation varies widely, and some compounds
may not cause enough to induce cell death (80, 81). The mechanism by which this occurs
seems to include an inhibition of perioxidase and catalase, which break down ROS (81).
One concern associated with use of azoles for irradiation of biofilms is the presence of
persister cells, which remain viable following treatment with supra-MIC concentrations
due to heritable phenotypic differences in these cells. This is often evidenced by the
biphasic killing pattern that is associated with azole treatment, particularly miconazole, in
which a fraction of the original cell population remains viable and resistant following
drug treatment (79). A study by Bink et al. demonstrated that miconazole-tolerant
persister cells were linked to a ROS-detoxifying effect due to expression of superoxide
dismutases within the cells of a C.albicans biofilm; inhibition of genes associated with
production of superoxide dismutases resulted in a reduced number of persister cells in
miconazole-treated biofilms (82). However, though azoles are effective antifungal drugs
against planktonic cells, only miconazole has effective activity against C. albicans
biofilms, and often results in biphasic killing, leading to the emergence of persister cells
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(79). Additionally, resistance can also be achieved by either overexpression of or
mutations of the target of the drug, C14 lanosterol demethylase . Resistance in Candida
spp. has also been attributed partially to overexpression of the genes encoding the drug
efflux pumps of the ABC and MFS classes, including CDR1, CDR2 and MDR1 (76).
Flucytosine is a commonly used clinical antifungal. It is endocytosed by the cell
and subsequently converted into its metabolically active form, 5-fluorouracil. This
compound then inhibits cell growth by inhibition of both protein synthesis and DNA
replication). However, C.albicans commonly show resistance to this antifungal; with
about 10% displaying intrinsic resistance, and around 30% developing resistance during
clinical treatment using this compound (76). Resistance is associated with mutations in
the FCy2 gene, which encodes purine-cytosine permease, which is necessary for
successful uptake of the drug by the cell, in the FCy1 gene, encoding cytosine deaminase
converts flucytosine to its active form, 5-flurouracil, or in the FUR1 gene, encoding
phosphoribosyltransferase, which converts 5-fluorouracil to 5-fluorouridine
monophosphate (76). A recent study by Gopinathan et al. examined antifungal resistance
Candida isolates from two hundred vaginal candidiasis patients in Chennai, and found
that mutant FUR1 was present in all species that displayed flucytosine resistance.
Furthermore, the incidence of resistance to this antifungal drug was prevalent among all
the isolates and a greater percentage were resistant to 5-flucytosine than the other
antifungals tested, around 41.66% (83). Due to high prevalence of clinical resistance to
this antifungal, combination antifungal therapy has often been employed when using this
drug in a clinical setting. However, there is evidence that treatment with flucytosine can
contribute to other antifungal resistance, particularly to azoles. A recent study conducted
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by Steier et al. demonstrated that subinhibitory concentrations of flucytosine antagonized
fluconazole activity in different isolates of C. glabrata. The mechanism behind this
antagonism was due to flucytosine activation of Pdr1, a transcription factor that
upregulates the expression of CDR1, a multidrug transporter encoding gene (84). The
activation of this gene is associated with azole resistance in C. glabrata (86). The
contribution of resistance to flucytosine to resistance to azoles has been established in
other Candida species as well. C. lusitaniae isolates that contained mutations in FCY1 or
FCY2, displayed resistance to fluconazole as well (87).
In contrast to flucytosine, resistance of Candida isolates to amphotericin B, is not
as commonly observed. Amphotericin B is an agent of the polyene class of antifungals;
which are naturally occurring polyketides produced by Streptomyces spp (88). It
effectively binds to ergosterol in the cell membrane of fungi to form pores, which can
eventually lead to cell death (76). Resistance to this class of antifungals is defined as
displaying a MIC that is greater than 2ug/mL (76). The molecular mechanisms
contributing to resistance to amphotericin B are poorly understood, but usually associated
with changes in the molecular composition of the cell membrane, particularly decreases
in ergosterol content. This decrease is usually due to gene mutations in genes that encode
enzymes that are involved in ergosterol synthesis, usually ERG3, leading to a concurrent
increase in the content of other sterols in the cell membrane (76). Resistance in both
Candida and Cryptococcus clinical isolates was associated with a low level of ergosterol
content in the cell membrane (89).
Echinocandins have gained widespread clinical use as antifungal drugs to their
ability to inhibit fungal cell wall synthesis in most species of Candida, and are
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particularly useful against Candida that displays antifungal resistance to other clinical
drugs (55). The fungicidal activity of this class of large lipopeptides is due to the
inhibition of beta-1,3-glucan production, by targeting the catalytic subunit of Fks1 within
the beta-1,3-glucan synthase complex (55). These compounds are chemically modified
from naturally produced fungal products. They are thought to intercalate into the
phospholipid bilayer of the cell membrane of exposed fungi using the N-linked acyl lipid
side chains present in each agent, although the exact chemical composition of this side
chain varies with each (90). This class of drugs is clinically effective, and causes
relatively few adverse effects in patients, due in part to the lack of a mammalian target.
The echinocandins also display far fewer drug interactions than other antifungal classes
of drugs, such as azoles (72). There is evidence that caspofungin, an echinocandin, is
more effective against C. albicans biofilms than either fluconazole or amphotericin B
(91). There are several distinct drugs in this class of antifungals, but for all agents within
this class, susceptibility is defined as possessing drug minimum inhibitory concentrations
(MICs) of ≤2ug/mL. Furthermore, the MIC90, or the MIC at which 90% of Candida
isolates are susceptible are usually less than 2ug/mL (90). However, although resistance
rates to echinocandins are fairly low, instances of resistance has been observed both in
clinical and laboratory settings (92). Resistant strains of C. albicans are often found to
contain specific point mutations at two hot spots in the FKS1 gene, usually at the serine
at position 645, which lead to amino acid substitutions that occasionally, but not always,
confer resistance (90). Studies have shown that elevated chitin content within the cell
wall of various species of Candida also confers resistance to echinocandins, likely due to
increased stability of the cell wall that prevents lethal amounts of damage from occurring
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(93). A paradoxical effect on growth on strains of Candida is well-reported in the
literature, at which isolates are found to be capable of growing at concentrations far
exceeding the MICs of different agents. This effect seems to rely in part, on the ability of
the isolate to remodel the cell wall to contain more chitin than is usually observed. A
study by Shields et al. revealed that several varieties of Candida exhibited paradoxical
growth when treated with caspofungin, an echinocandin, but this effect was eliminated
using both chitin synthase inhibitor nikkomycin Z and calcineurin pathway inhibitors
(94).
Although these antifungal drugs are distinct in form and function, they have been
all found to the ability to induce the production of reactive oxygen species (ROS) in
fungal cells (79). Among the azoles, miconazole is particularly effective at inducing ROS
accumulation within planktonic fungal cells (95). In addition, miconazole is the only
agent within this class that has produced significant levels of ROS accumulation in
biofilm cells. However, ROS accumulation did not result in increased apoptosis nor did
quenching of ROS lead to enhanced survival of C. albicans biofilm cells (96).
Autooxidation of amphotericin B can lead to oxidative damage and death of C. albicans,
evidenced by a study by Sokol-Anderson et al. in which treatment with this antifungal
under hypoxic conditions reduced the oxidative damage to the cells by 80%. This study
demonstrated that catalase and superoxide dismutase conferred a protective effect to C.
albicans, allowing them to resist killing by amphotericin B (97).
Finding methods to increase ROS accumulation in Candida planktonic and
biofilm cells, in order to promote apoptosis, is currently being pursued as a possible
alternative antifungal treatment. One such method is the use of photodynamic
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inactivation, which typically uses a compound that acts as a photosensitizer, producing
ROS in response to activation by light of the appropriate wavelength (79). This method
has been known to possess the ability to eliminate different types of microorganisms
since the early 1900’s, but the increases use of antibiotics since the mid-20th century
caused this form of therapy to fall into disuse. It began to be reevaluated as an
antimicrobial therapy after increases in antibiotic resistance made finding alternative
clinical strategies necessary (98). To enhance the selectivity of these compounds, they are
often engineered to either be taken up by target cells or to attach to them in some manner
(104). Studies involving C. albicans suggest this form of therapy works faster than other
antifungal treatments, and can be effectively used to eliminate microorganisms showing
resistance to other agents (98).
Antimicrobial photodynamic therapy (APDT) begins when light of a specific
wavelength is absorbed by the photosensitizing compound; this causes the promotion of
the compound from the ground state to a photoactive triplet state, in which the molecules
of the compound can pass either excess energy or their electrons to nearby biomolecules.
This can occur by one of two mechanisms. The first mechanism utilizes the localized
production of cytotoxic radicals from nearby substrates, the second generates singlet
oxygen from molecular oxygen, which can then react with nucleic acids, proteins or other
biomolecules (98). Singlet oxygen production can lead to cellular damage through many
targets, including inactivation of enzymes leading to disruption of cellular processes and
peroxidation of lipids, causing membrane disruptions and possibly leading to lysis of
cellular membranes; however, the exact photosensitivity effect on cells varies depending
upon factors such as media composition (99).
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Clinically, the only photosensitizing compounds used to date are phenothiazinium
salts, such as methylene blue and Toluidine Blue, which are often used together and
activated with red light. This therapy is often used to sterilize during dental procedures
and to treat periodontitis (98). However, the effectiveness of APDT against fungal cells
has been established, making this form of alternative treatment attractive as a potential
method of combating fungal infections, particularly superficial ones. A recent study
conducted by Pereira et al. indicated that photodynamic inactivation using methylene
blue as a photosensitizer was effective as significantly decreasing viability of biofilm
cells formed by different microorganisms, including C. albicans (100). Furthermore, a
study by Zeina et al. provided evidence that ketatinocytes exposed to methylene blue and
visible light, had kill rates that were 18-200 fold lower than that for cutaneous microbial
species under identical conditions, indicating that this form of treatment could be used
without severe damage occurring to nearby tissues (101, 102).
There has been little evidence that APDT has mutagenic effects on treated cells,
and as the therapy is nonspecific and damages many cellular components, complete
resistance from repeated use would be unlikely to occur (103, 98). Singlet oxygen reacts
strongly with nucleic acids, which could have a potential mutagenic effect, however, this
effect does not prevent killing of D. radiodurans, a bacteria with a DNA repair
mechanism efficient enough to allow the organism to survive doses of ionizing radiation,
by APDT (105).
The main mechanisms of fungal resistance to APDT are the same mechanisms
that govern other types of drug resistance, particularly those related to efflux of the drugs.
The ABC and MFS transporters in C. albicans have been reported to decrease the
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effectiveness of APDT using methylene blue (106). This would suggest that targeting
photosensitizers to the outside of fungal membranes may be effective at circumventing
resistance mechanisms in fungal cells. Intrinsic mechanisms of resistance seem to be the
main factors contributing to the resistance of microorganisms to APDT. C. albicans
possess an oxidative stress response against ROS, such as expression of catalase Cta1 and
superoxide dismutases, Sod1 and Sod 5 (107, 108). The expression of catalase is thought
to enhance the pathogenicity of C. albicans by allowing the fungi to be less sensitive to
oxidative damage by neutrophils and exogenous peroxide, and strains that did not express
catalase were less virulent in a murine model of disseminated candidiasis (107). Sod
proteins convert superoxide radicals into hydrogen peroxide, which is less toxic to the
cell. Sod1 (CuZnSOD) expression in C. albicans is primarily confined to the cytosol; this
species also expresses Sod3 (MnSOD) in the mitochondria. In addition to these Sod
proteins, C. albicans also express Sod4, Sod5 and Sod6. Sod5 is upregulated during the
transition from yeast to hyphal morphology, during both osmotic and oxidative stress,
and when grown in certain media (109, 108). Sod5 is an important virulence factor;
strains deficient in expression were more sensitive to oxidative damage by hydrogen
peroxide and less virulent in a mouse model of infection (108). Resistance to oxidative
damage may also be achieved via alternative mechanisms. C. albicans express six major
heat shock proteins (HSPs), which respond to environmental stresses such as oxidative
stress, nutrient deprivation or temperature elevation by preventing the aggregation of
damaged or misfolded proteins, which can potentially lead to cell death (6). Expression
of HSPs is upregulated when the transcription factor Hsf1 becomes hyperphosphorylated
as a cellular response to stress; it then activates the transcription of genes that contain
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heat shock elements (HSEs), including those encoding various HSPs. Hsf1 activation and
subsequent upregulation of HSPs is necessary for full virulence of C. albicans in a mouse
model of systemic candidiasis (110). The expression of small heat shock proteins
(sHSPs) may also contribute to the ability of C. albicans to resist oxidative stress. Thus
far, six sHSPs have been identified in C. albicans; they function to prevent the
aggregation of damaged or misfolded proteins, which may become toxic to the cell (6).
sHSPs may contribute to the pathogenicity of C. albicans as well. A study by Mayer et
al. demonstrated the critical role of Hsp21 in resistance of oxidative and thermal stresses,
hyphal development, defects in adhesion and invasion into endothelial and epithelial
tissues, and resistance to killing by neutrophils (111). However, it remains to be
elucidated whether these intrinsic mechanisms of responding to oxidative stress confers
resistance to APDT using various photosensitizing compounds.
APDT continues to be a promising alternative treatment for bacterial and fungal
infections, particularly in strains that are resistant for other antimicrobial treatments. The
development of new photosensitizing compounds may lead to more effective clinical
treatments for invasive candidiasis, but this is an area that requires further elucidation.
1.10 Cationic conjugated polyelectrolytes and oligomers as antimicrobial agents
The development of antimicrobial cationic compounds has been investigated as an
alternative treatment to traditional antimicrobial agents. The positive charges are able to
effectively interact with surfaces, polymers, peptides and particles; which can confer
antimicrobial properties by causing disruption to membranes. In addition, many of these
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compounds display low toxicity to mammalian cells, which is of utmost importance when
considering the possible use of agents clinically (112).
There are several aspects that influence the mechanisms of antimicrobial activity
and efficacy. The molecular weight of the agent may influence the permeability of the
compound through the cell wall. The presence of a counterion may influence the
solubility of the compound. The relative hydrophobicity and hydrophilicity of the agent
and the overall structure and geometry may also affect the activity, interactions with
cellular structures, solubility, and permeability of the compound (113).
In this study, we tested two photoactivatible biocidal compounds, one (PPE)based cationic conjugated polyelectrolyte (CPE), PPE-DABCO, and one oligo-phenylene
ethynylene (OPE), EO-OPE-1 (DABCO). The PPEs and OPEs are conjugated
electrolytes, containing double or triple bonds separated by a single bond. These
compounds form ions in solution and are fluorescent (114, 115).
The antibacterial properties of PPE-based cationic conjugated polyelectrolyte
were first described by Lu et al. In this study, they demonstrated the effectiveness of the
light-induced biocidal activity following the coating of the agent to the surface of both
Gram negative and Gram positive bacteria (115). The antimicrobial properties of (PPE)based cationic conjugated polyelectrolytes (CPEs) have been found to correlate to the
length of the polymerized chain; the shortest polymer (n=7) tested in one study showed
the greatest degree of antibacterial activity against both Gram negative and Gram positive
bacteria (116).
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Previous work by Wang et al. revealed that (PPE)-based cationic conjugated
polyelectrolytes (CPEs) and oligo-phenylene ethynylenes (OPEs) were effective at
breaching the outer membrane of bacterial cells and interacting with the cytoplasmic
membrane, creating damage to the cell surface. This interaction was effective at killing
bacterial cells, even in the absence of photoactivation of the compounds (117). It has
been demonstrated that while Gram negative bacteria exposed to CPE and OPE
compounds in the dark show evidence of damage to the cell envelope, plasma membrane
and some damage to the cytoplasm, Gram positive bacteria remained intact upon
exposure to the same compounds in the dark, and the agents bound to and disrupted the
cell wall only (118). This indicates that the mechanism by which these agents are able to
inflict damage to cells in the absence of photoactivation depends on the cellular structure
and organization of the organism.
In addition, both the CPE and OPE compounds possess light-activated biocidal
activity, which is mediated by the ability of the agents to generate singlet O2 upon
irradiation with UV-visible light. A study by Wang et al. demonstrated that E. coli
exposed to CPEs and OPEs in the presence of UV-light showed evidence of covalent
modifications to both plasmid DNA and proteins, which was attributed to oxidative
pathways activated by the generation of singlet oxygen and other ROS (118).
1.11 Antifungal activities of PPE-DABCO and EO-DABCO
Previous work by Wang et al. has demonstrated the effectiveness of both PPEDABCO and EO-DABCO against S. cerevisiae. Both compounds were effective at
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significantly reducing the viability of vegetative yeast cells in the dark; and upon UVirradiation, both compounds demonstrated even more potent antifungal activity (119).
In this study, we tested the antifungal activity of PPE-DABCO and EO-DABCO
against a clinically relevant pathogenic fungus, C. albicans, to determine whether these
compounds could effectively reduce the viability of the yeast in the dark and upon light
activation of the compounds. Furthermore, we tested the ability of the compounds to
inhibit the yeast to hyphal transition of these cells, as that is an important factor that
contributes to the virulence of the fungi, and the ability of fungi to form biofilms. We saw
reductions in the viability of the yeast upon photoactivation of the compounds, but
treatment with the agents in the dark failed to reduce viability significantly. We also
demonstrated that light-irradiation of the compounds could inhibit the yeast to hyphal
transition of C. albicans. We were able to localize both of the compounds to the cell wall
of both yeast and hyphal cells and photoactivate the agents using the 405nm confocal
laser, which allowed us to directly visualize and subsequently quantify changes to the
cells over time. However, treatment with the compounds, either in the dark or upon
photoactivation, did not reduce the ability of persister cells to form mature biofilm
structures, complete with hyphal development. We were able to conclude that these two
compounds are able to act as potent antifungal agents upon photoactivation, reducing
both the viability of yeast cells, as well as inhibiting the yeast to hyphal transition of
individual cells.
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Chapter 2 Materials and Methods
2.1 Antifungal testing of PPE-DABCO and EO-DABCO
This study utilized concentrations of PPE-DABCO and EO-DABCO at 20µg/mL.
These concentrations were based on the previous antifungal testing concentrations used
by Wang et al. in which all compounds were tested at a concentration of 10µg/mL. (119).
We doubled the concentration after preliminary testing with 10µg/mL with each
compound was not deemed significantly effective (data not shown).
2.1.1 Synthesis of PPE-DABCO and EO-DABCO
The synthesis of these compounds has been described previously (114, 117, 120,
121). The structures of these compounds are included in Table 2.1.

Table 2.1. Structures of Biocidal Compounds
Structure

Name of Compound

PPE-DABCO

EO-OPE-1 (DABCO)
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2.1.2 CFU assay
C. albicans 5314 were grown overnight (16-18h) in 5mL YPD broth (scraping
taken from LiN2 ATCC stock) at 30C in the orbital shaker, 300rpm. For light exposure
experiments, 100µL of the yeast suspension was added to 900µL of PBS in VWR Glass
Vials, Short Form Style, Phenolic Cap on, 0.5 Dr. For dark experiments, 100µL of yeast
suspension was added to 900µL of YPD broth in VWR-International 14mL sterile roundbottom culture tubes (60818-689). Either PPE-DABCO or EO-DABCO was added to a
final concentration of 20µg/mL; untreated controls included for both dark and light
exposure experiments. The light irradiation experiments were carried out in a
photoreactor (4 UV-lamps, LZC-ORG, Luzchem Research Inc., Ottawa, Canada). LZC420 (centered at ~420 nm) was used to activate PPE-DABCO and UVA (centered at
~350 nm) was used to activate EO-DABCO for 30min at room temperature. For dark
exposure experiments, yeast were incubated with or without the compounds for 2h on
orbital shaker, 30C, 300rpm. Following exposure, cultures were diluted 1:10^4 in PBS,
and 50µL of each dilution was plated onto YPD agar plates. Plates were incubated
overnight (16-18h) at 37C. Colonies were counted by ImageJ (1.48p, Java 1.7.0_07 (64bit), NIH) analysis of digital photographs. Both the light and dark experiments were
performed in triplicate.
2.1.3 Confocal imaging of C. albicans cultures to assess yeast to hyphal transition
C. albicans 5314 were grown overnight (16-18h) in 5mL YPD broth (scraping
taken from LiN2 ATCC stock) at 30C in the orbital shaker, 300rpm. For light exposure
experiments, 100µL of the yeast suspension was added to 900µL of PBS in VWR Glass

28

Vials, Short Form Style, Phenolic Cap on, 0.5 Dr. Either PPE-DABCO or EO-DABCO
was added to a final concentration of 20µg/mL. The light irradiation experiments were
carried out in a photoreactor (4 UV-lamps, LZC-ORG, Luzchem Research Inc., Ottawa,
Canada). LZC-420 (centered at ~420 nm) was used to activate PPE-DABCO and UVA
(centered at ~350 nm) was used to activate EO-DABCO for 30min or 60min at room
temperature. . Following exposure, cultures were diluted 1:10^4 in PBS, and 50µL of
each dilution was plated onto YPD agar plates. Plates were incubated for four days at
37C. A small loop of each sample was added to RPMI+300mg/L L-glutamine+0.165M
MOPS+0.2% glucose (pH 7.4) in a MatTek dish. Samples of each irradiated culture were
incubated either at room temperature for 1h in the dark, or at 37C for 3h or 24h in the
dark and immediately imaged on an Olympus FV1000 confocal microscope (PLAPON
60X O NA:1.42, 0.207µm/pixel x 0.207µm/pixel, Z depth 20 slices, 1.5µm/slice,
Sampling speed 2.0µs/pixel). A scraping from the original stock of C. albicans 5314 was
also used to grow a 24h biofilm for comparison purposes, by suspending the cells in the
same RPMI media and using this suspension to directly seed a MatTek dish. The samples
grown to 24h were first stained with 20µg/mL calcofluor-white prior to imaging; all other
samples were unstained. Analysis of images was performed in ImageJ (1.48p, Java
1.7.0_07 (64-bit), NIH).
2.1.4 Growth of 25h C. albicans biofilms under static conditions
C. albicans 5314 were grown overnight (16-18h) in 5mL YPD broth (scraping
taken from LiN2 ATCC stock) at 30C in the orbital shaker, 300rpm. For light exposure
experiments, 100µL of the yeast suspension was added to 900µL of PBS in VWR Glass
Vials, Short Form Style, Phenolic Cap on, 0.5 Dr. For dark experiments, 100µL of yeast
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suspension was added to 900µL of YPD broth in VWR-International 14mL sterile roundbottom culture tubes (60818-689). Either PPE-DABCO or EO-DABCO was added to a
final concentration of 20µg/mL; untreated controls included for both dark and light
exposure experiments. Cultures were exposed to either 420nm light to activate PPEDABCO, or UVA light to activate EO-DABCO for 30min at room temperature. For dark
exposure experiments, yeast were incubated with or without the compounds for 2h on
orbital shaker, 30C, 300rpm. Following exposure, yeast were counted with a
hemocytometer. Yeast were resuspended in RPMI+300mg/L L-glutamine+0.165M
MOPS+0.2% glucose (pH 7.4) at 1e6 yeast/mL. For biofilm growth an Ibidi CultureInsert for self-insertion (69842) was placed into the center of a MatTek Glass Bottom
35mm Microwell Dish, No. 1.5 coverglass (0.16-0.19mm), using sterilized tweezers.
Yeast suspensions were added to dishes by injecting 70µL into the center of each side of
insert. Biofilms were grown for 25h at 37C; calcofluor-white was then injected into each
biofilm at a final concentration of 20µg/mL. Biofilms were immediately imaged on an
Olympus FV1000 confocal microscope. Experiment was performed in triplicate per
condition; three fields per biofilm were analyzed using ImageJ (1.48p, Java 1.7.0_07 (64bit), NIH).
2.1.5 Live cell localization of PPE-DABCO and EO-DABCO in the cell wall of C.
albicans
C. albicans 5314 were grown overnight (16-18h) in 5mL YPD broth (scraping
taken from LiN2 ATCC stock) at 30C in the orbital shaker, 300rpm. The yeast were
counted with a hemocytometer and 1.0e6 yeast were washed in 1mL PBS one time at
10,000xg for 5min. The pellet was resuspended in1mL RPMI+300mg/L L30

glutamine+0.165M MOPS+0.2% glucose (pH 7.4) containing 20uM fluorescein. 150µL
of yeast were added to each of two channels of an Ibidi µ-slide VI0.4 luer (80601) using a
pipette. The slide was incubated at 30C for 1h to allow yeast to adhere. Following the 1h
incubation, either PPE-DABCO or EO-DABCO was added to one of the channels of the
slide at a final concentration of 20µg/mL. The slide was immediately imaged on an
Olympus FV1000 confocal microscope (PLAPON 60X O NA:1.42, 0.207µm/pixel x
0.207µm/pixel, Z depth 20 slices, 1.5µm/slice, Sampling speed 2.0µs/pixel), with the
imaging chamber heated to 37C. The PPE-DABCO or EO-DABCO and untreated
cultures were imaged as follows. Images of the untreated cultures were imaged initially,
immediately prior to beginning a 2h imaging session where the cultures treated with
either EO-DABCO or PPE-DABCO were imaged every 5 minutes with the 405nm laser
(14%, HV 830V, Gain 1); the 473nm laser was used to visualize the fluorescein to
generate a negative image of the growing cells that was used for image processing (1%,
HV 610V, Gain 1). Immediately following the 2h of imaging, the same initial field of the
untreated culture was again imaged with the same settings for comparative purposes.
Analysis of images was performed in ImageJ (1.48p, Java 1.7.0_07 (64-bit), NIH).
2.1.6 Live cell imaging of C. albicans biocidal testing of PPE-DABCO
C. albicans 5314 were grown overnight (16-18h) in 5mL YPD broth (scraping
taken from LiN2 ATCC stock) at 30C in the orbital shaker, 300rpm. The yeast were
counted with a hemocytometer and 1.0e6 yeast were washed in 1mL PBS one time at
10,000xg for 5min. The pellet was resuspended in1mL RPMI+300mg/L Lglutamine+0.165M MOPS+0.2% glucose (pH 7.4) containing 20uM fluorescein. 150µL
of yeast were added to each of two channels of an Ibidi µ-slide VI0.4 luer (80601) using a
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pipette. The slide was incubated at 30C for 1h to allow yeast to adhere. Following the 1h
incubation, PPE-DABCO was added to one of the channels of the slide at a final
concentration of 20µg/mL. The slide was immediately imaged on an Olympus FV1000
confocal microscope with the imaging chamber heated to 37C. The PPE-DABCO and
untreated cultures were imaged as follows. For the experiments in which PPE-DABCO
treated cultures were continuously exposed to the 405nm laser (14%, HV 830V, Gain 1),
a single field of the untreated culture was imaged at the initial time point and after 2h of
hyphal growth in the dark. During the two hours between these images, a single field of
the PPE-DABCO treated culture was imaged every 5 minutes for 2h with the 405 laser
(PLAPON 60X O NA:1.42, 0.207µm/pixel x 0.207µm/pixel, Z depth 20 slices,
2.0µm/slice, Sampling speed 2.0µs/pixel); the 473nm laser was used to visualize the
fluorescein to generate a negative image of the growing cells that was used for image
processing (1%, HV 610V, Gain 1). This experiment was performed twice and analyzed
using the surface-rendering feature of Imaris software (X63, 6.1.5, Bitplane, Zurich,
Switzerland) and Minitab® (16.2.4, LEADTOOLS © 1991-2004, LEAD Technologies,
Inc.). A single control experiment was performed using the exact imaging conditions as
above, with the only change being the omission of PPE-DABCO treatment to the culture.
The single control experiment was analyzed using ImageJ (1.48p, Java 1.7.0_07 (64-bit),
NIH).
For the experiments controlled for phototoxicity effects, a single field of the PPEDABCO culture and untreated culture were exposed to the 405nm laser (14%, HV 830V,
Gain 1) to activate the PPE-DABCO for a total of 4 scans per field (1024x1024,
0.207µm/pixel, Z depth 20 slices, 1.5µm/slice, scanning speed 2.0µs/pixel). The cultures
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were simultaneously scanned with the 473nm laser to fluoresce the fluorescein.
Following this scan, the 405nm laser was shut off, and the PPE-DABCO and untreated
fields previously exposed to the 405nm laser, along with a PPE-DABCO and untreated
field not previously exposed to the 405nm laser, continued to be scanned for a following
2h, Z-stacks of each field taken every 10min (PLAPON 60X O NA:1.42, 0.207µm/pixel
x 0.207µm/pixel, Z depth 20 slices, 1.5µm/slice, Sampling speed 2.0µs/pixel). The
473nm laser was used to visualize the fluorescein to generate a negative image of the
growing cells that was used for image processing (1%, HV 610V, Gain 1). Experiment
was performed in triplicate. Analysis of images was performed in ImageJ (1.48p, Java
1.7.0_07 (64-bit), NIH).
2.1.7 7-AAD viability assay
C. albicans 5314 were grown overnight (16-18h) in 5mL YPD broth (scraping
taken from LiN2 ATCC stock) at 30C in the orbital shaker, 300rpm. For light exposure
experiments, yeast suspension (1e6 cell/mL in PBS) were transferred to VWR Glass
Vials, Short Form Style, Phenolic Cap on, 0.5 Dr. For dark experiments, , yeast
suspension (1e6 cell/mL in PBS) were transferred to 1.5uL polypropylene centrifuge
tubes. PPE-DABCO was added to a final concentration of 20µg/mL to cultures
suspended in PBS at 1e6 cells/mL. Cultures were incubated with PPE-DABCO for 30
minutes prior to washing 3 times in PBS by centrifugation at 10,000xg for 5 minutes,
followed by siphoning off the supernatant and resuspending cells in PBS, at 1e6cells/mL.
Untreated controls included for both dark and light exposure experiments. The light
irradiation experiments were carried out in a photoreactor (4 UV-lamps, LZC-ORG,
Luzchem Research Inc., Ottawa, Canada). LZC-420 (centered at ~420 nm) was used to
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activate PPE-DABCO treated cultures and untreated cultures for 30min at room
temperature. For dark exposure experiments, yeast were incubated, following
pretreatment with PPE-DABCO and washing, for 30 minutes at room temperature in the
dark. Following exposure, 70µL of each sample was inoculated into a single side of an
Ibidi Culture-Insert for self-insertion (69842) placed into the center of a MatTek Glass
Bottom 35mm Microwell Dish, No. 1.5 coverglass (0.16-0.19mm), using sterilized
tweezers. 7-AAD (Invitrogen, A1310) was added to a final concentration of 10µg/mL,
and calcofluor-white was added to a final concentration of 10µg/mL, to each sample.
Images were taken using a laser-scanning confocal microscope (UPLSAPO 10X 2
NA:0.40, 0.124µm/pixel x 0.124µm/pixel, 2.0µm/Z slice, Sampling speed 2.0µs/pixel).
Images were analyzed using ImageJ (1.48p, Java 1.7.0_07 (64-bit), NIH). Both the light
and dark experiments were performed in triplicate, three fields per sample per repeat
were analyzed.
2.1.8 7-AAD viability assay-confocal 405nm laser activation of PPE-DABCO
C. albicans 5314 were grown overnight (16-18h) in 5mL YPD broth (scraping
taken from LiN2 ATCC stock) at 30C in the orbital shaker, 300rpm. For light exposure
experiments, yeast suspension (1e6 cell/mL in PBS) were transferred to VWR Glass
Vials, Short Form Style, Phenolic Cap on, 0.5 Dr. For dark experiments, , yeast
suspension (1e6 cell/mL in PBS) were transferred to 1.5uL polypropylene centrifuge
tubes. PPE-DABCO was added to a final concentration of 20µg/mL to cultures
suspended in PBS at 1e6 cells/mL. Cultures were incubated with PPE-DABCO for 30
minutes prior to washing 3 times in PBS by centrifugation at 10,000xg for 5 minutes,
followed by siphoning off the supernatant and resuspending cells in PBS, at 1e6cells/mL.
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70µL of each sample was inoculated into a single side of an Ibidi Culture-Insert for selfinsertion (69842) placed into the center of a MatTek Glass Bottom 35mm Microwell
Dish, No. 1.5 coverglass (0.16-0.19mm), using sterilized tweezers. 7-AAD (Invitrogen,
A1310) was added to a final concentration of 10µg/mL. Untreated samples were included
in each experiment. One field of the untreated culture and one field of the PPE-DABCO
treated culture were imaged using a laser-scanning confocal microscope ((UPLSAPO
10X 2 NA:0.40, 0.124µm/pixel x 0.124µm/pixel, 2.0µm/Z slice, Sampling speed
2.0µs/pixel) with the 405nm laser (7%, HV 830V, Gain 1) for 8 scans each at 8 minute
intervals. Calcofluor-white was added to each sample at a final concentration of
10µg/mL, and the previous fields were scanned again, along with one field of the
untreated culture and one field of the PPE-DABCO treated culture that was not
previously exposed to the 405nm laser. For the final scans, the 405nm laser was lowered
to 2%. Images were analyzed using ImageJ (1.48p, Java 1.7.0_07 (64-bit), NIH).
Experiment was performed in triplicate.
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Chapter 3. Results and Discussion
3.1. Effect of PPE-DABCO and EO-DABCO on C. albicans viability in the light and
dark
In order determine the level of effectiveness of the antifungal activity of PPEDABCO and EO-DABCO against a laboratory strain of C. albicans in both the light and
dark, the ability of C. albicans to form colonies on YPD agar was used to assess
effectiveness of the compounds at reducing the viability of yeast. We first exposed
suspension cultures of C. albicans to 20ug/mL of either PPE-DABCO or EO-DABCO for
2h in the dark prior to plating dilutions on YPD agar and incubating overnight at 37C.
The resultant colonies were quantified and normalized to the untreated control plates. As
seen in Figure 3.1, exposure to neither compound resulted in any significant reduction in
CFUs per plate.

1.8
1.6

Average CFUs/plate

1.4
1.2
1
0.8
0.6
0.4
0.2
0
Untreated

PPE-DABCO (20ug/mL)

EO-DABCO (20ug/mL)

Figure 3.1. Exposure of C. albicans to PPE-DABCO (20ug/mL) or EO-DABCO (20ug/ml) in the dark. C.
albicans were exposed to indicated concentrations of either PPE-DABCO (20ug/mL) or EO-DABCO
(20ug/ml) in the dark for 2h prior to diluting samples 1:10^4 and plating on YPD agar. Plates were
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incubated at 37C overnight (18-20h) prior to quantification. This experiment was performed in triplicate;
error bars represent standard deviation.

We then decided to test the antifungal activities of PPE-DABCO and EODABCO upon 30 minute light exposure by assessing colony formation on YPD agar
plates following treatment (Figure 3.2). Upon 30 minutes of exposure to UV-light, the
cultures exposed to 20ug/mL of EO-DABCO showed an average 72.6% reduction in
CFUs/plate and an average reduction of percent area cellularity per plate of 82.8% from
the original untreated cultures. The cultures treated with 20ug/mL PPE-DABCO and
exposed to 420nm light for 30 minutes showed an average reduction of CFUs/plate of
95.4% and an average reduction of percent area cellularity per plate of 91.5% over the
untreated culture that was unexposed to light. However, while the reduction in the
colonies formed by C. albicans treated with either compound was observable, a distinct
phototoxic effect of exposure to UV-light and 420nm light was observable in cultures
untreated with either compound. Exposure to UV-irradiation caused an average reduction
in the number of CFUs/plate of 2.6% and a reduction in the average percent area
cellularity per plate of 54.5% vs. the untreated control unexposed to the light.
Furthermore, the untreated cultures exposed to 420nm light for 30 minutes displayed an
average reduction in the number of CFU/plate of 64.1% and an average reduction in the
percent area cellularity per plate of 72.5% over the untreated controls unexposed to light
irradiation. However, the phototoxic effects alone did not account fully for the reduction
of colony formation in cultures treated with either compound. The cultures treated with
EO-DABCO prior to irradiation showed a 70.0% decrease in the average CFUs/plate and
a 28.4% decrease in the average percent area cellularity per plate compared to the UV-
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irradiated untreated controls. In addition, the cultures treated with PPE-DABCO and
exposed to light displayed a 31.4% decreased in the average number of CFUs/plate and a
19.1% decrease in the percent area cellularity per plate compared to the 420nm light
irradiated controls.

Figure 3.2. Light activation of EO-DABCO and PPE-DABCO leads to a reduction in C. albicans colony
formation on YPD agar plates. C. albicans were exposed to UV-light irradiation or 420nm-light irradiation
for 30 min to activate EO-DABCO (20ug/mL) or PPE-DABCO (20ug/mL), respectively. Untreated
controls were concurrently exposed to UV-light irradiation or 420nm-light irradiation for 30 min at
identical concentrations of yeast/mL, as indicated in the methods section. All samples were diluted 1:10^4
prior to plating on YPD agar, and incubated overnight (~18-20h) at 37C. Experiment performed in
triplicate. Statistical significance assessed via a 2-sample, unequal variance T-test. Star indicates pvalue<0.05.

After determining that photoactivation of the compounds caused a reduction in
CFUs, we then wanted to assess the viability of yeast exposed to 20ug/mL PPE-DABCO,
both in the dark, and after photoactivation of the agent with 420nm light. We wanted to
determine if photoactivation of the compounds were causing an increase in cell death. We
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pre-treated C. albicans cultures with 20ug/mL PPE-DABCO for 30 minutes in the dark,
prior to exposing the cultures to 420nm light for 30 minutes. Following light irradiation,
we performed a viability test using 7-AAD at 10ug/mL (Figure 3.3-3.4). As 7-AAD is
excluded from cells with an intact cell membrane, it can be used to detect cells that have
increased membrane permeability, a marker of dead or dying cells.
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Figure 3.3. Confocal images of C. albicans viability test with 7-AAD. (A-C) Untreated
dark culture. (D-F) Untreated culture exposed to 420nm light irradiation for 30min. (G-I)
PPE-DABCO (20ug/mL) treated dark culture. (J-L) PPE-DABCO (20ug/mL) treated
culture exposed to 420nm light irradiation for 30min. Images analyzed using ImageJ (1.48p,
Java 1.7.0_07 (64-bit), NIH).
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Figure 3.4. C. albicans viability test with 7-AAD. Quantification of images represented in Figure 3.3.
Experiment performed in triplicate; three fields per sample per experiment were quantified. Images
analyzed using ImageJ (1.48p, Java 1.7.0_07 (64-bit), NIH). Statistical significance assessed via a 2sample, unequal variance T-test. Star indicates p-value<0.05.

The result of the 7-AAD viability test further supports our previous observation
that the viability of C. albicans yeast in suspension decreases significantly upon
photoactivation of PPE-DABCO. A significant decrease in viability was also observed in
cultures treated with PPE-DABCO in the dark, which was previously unobserved by our
CFU assay. For the viability assay, we pretreated the cultures of C.albicans with PPEDABCO for 30 minutes in the dark, prior to washing away the excess agent and exposing
the cultures to 420nm light-irradiation. As we were able to still able to achieve significant
decreases in viability upon photoactivation of the compound, we concluded that singlet
oxygen generated by excess agent in solution could not fully explain the decrease in
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viability; which indicates that some interaction of the agent with the cell itself is likely
and this interaction may be critical for the accumulation of enough reactive oxygen
species to induce apoptosis. Furthermore, although our CFU assay indicated that some
level of phototoxicity may be occurring in untreated cultures exposed to 420nm light
(Figure 3.2), the viability assay with 7-AAD indicated that there is not a significant
increase in apoptotic or necrotic cells in untreated samples undergoing light-irradiation.
That may indicate that any phototoxicity effects on untreated cultures may not involve an
increase in cell death.
From these results, we were able to conclude that light irradiation is necessary to
achieve the full antifungal effects of these compounds. While we did observe a highly
reproducible phototoxic effect of light irradiation on the untreated suspensions of C.
albicans in our CFU assay, it is unclear what is mechanistically occurring. The presence
of the photo-activated agents did effectively reduce colony formation over these
untreated controls, indicating a light-inducible antifungal effect of these compounds can
effectively reduce the numbers of viable yeast in suspension. This was further supported
by a significant reduction in the viability of C.albicans yeast that were exposed to PPEDABCO and irradiated with 420nm light.
3.2 Localization and activation of PPE-DABCO and EO-DABCO in the cell wall
To ascertain whether the localization of PPE-DABCO and EO-DABCO could be
detected using a confocal microscope, live-cell laser-scanning confocal imaging using a
405nm laser was used to visualize the compounds relative to the cells, taking advantage
of the inherent fluorescent properties of the compounds. Both PPE-DABCO and EO-
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DABCO signals could be detected both yeast and growing hyphae (Figure 3.5 C-F). The
signal from the EO-DABCO was less intense than that of the signal from the PPEDABCO when activated by the 405nm laser, but that can possibly be attributed to
differences in the optimal activation wavelengths between the two compounds: ~420nm
for PPE-DABCO and UVA wavelengths for EO-DABCO. However, we were not able to
ascertain whether the signal was localized exclusively to the cell wall of the cells. More
experiments are required to determine the extent to which these compounds are able to
penetrate the cell. Interestingly, the 405nm laser was able to photoactivate both
compounds and inhibit hyphal growth, as evidenced by the presence of shortened hyphae
after 2h of growth and the failure of many of the yeast to undergo the transition to hyphal
form. However, this could be due to an increase in cell death, as evidenced by previous
experiments. Surprisingly, what appears to be cell debris in the cultures treated with PPEDABCO and activated with the 405nm laser is visible in the 2h images, but was not
present in either the untreated controls, nor the EO-DABCO treated cultures, which may
indicate distinct differences in mechanistically how treatment of C. albicans with the
compounds inhibits hyphal growth or possibly induces cell death (Figure 3.5 C and D).
As a control for these experiments, untreated samples of the same C. albicans culture
were incubated under identical conditions, and imaged at the initial time point and
following 2h growth (Figure 3.5 A and B). The untreated yeast were able to undergo the
transition to hyphal form in this time period, with no observable yeast after 2h. This
indicates that photo-activation of these compounds during live cell imaging could serve
as a novel method of directly observing the effects of these compounds on an individual
cellular level.
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Figure 3.5 Live cell imaging of C. albicans allows visual localization of PPE-DABCO and
EO-DABCO in the cell wall of yeast and activation with the 405nm laser inhibits hyphal
development. A) Initial DIC image of an untreated culture and B)DIC image of untreated
culture following 2h of hyphal growth. C) DIC image of culture treated with PPE-DABCO
(20µg/mL) following 2h of growth and D) Fluorescent signal from PPE-DABCO activated
with 405nm laser. E) DIC image of culture treated with EO-DABCO (20µg/mL) following
2h of growth and F) Fluorescent signal from EO-DABCO activated with 405nm laser.
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3.3 Live cell imaging reveals activation of PPE-DABCO inhibits yeast to hyphal
transition in C. albicans
The dual observation that the 405nm confocal laser could be used to both localize
PPE-DABCO to visualize localization of the compound to activate the compound and
inhibit the hyphal growth of C. albicans led to the conclusion that the dynamics of hyphal
development during activation of the compound could be directly visualized on the basis
of individual cells. As many of our previous experiments tested the biocidal activity of
these compounds on the level of a population of cells, the dynamic temporal responses of
individual cells upon activation of this compound remained unclear. To better elucidate
these responses, we performed a series of live-cell experiments, in which the 405nm laser
was allowed to activate the PPE-DABCO present in the cell wall of the yeast every five
minutes for 2h. Images were taken every five minutes for two hours. The fluorescein
included in the culture was excluded by the cells, generating a negative image of the cells
that was used to quantify the data using ImageJ (1.48p, Java 1.7.0_07 (64-bit), NIH).
(Figure 3.6). Prior to beginning the imaging session, the yeast were allowed to adhere to
the surface of the slide for 1h. Once adhered, little to no movement of the original yeast
cell occurred, which allowed tracking of the growth of the surface-rendered cells from
frame to frame of the 3D-projected image (Figure 3.7). This was verified by tracking the
location of the centroid of the Imaris surface-rendered object, defined by both the x and y
position, during the two hours of growth (Figure 3.8). This allowed us to easily quantify
the differences in area (µm^2) and volume (µm^3) of individual surface-rendered objects
over time, which gave us an objective method for assessing the temporal effects of
activation of PPE-DABCO on the growing hyphae (Figure 3.9 A and B). As the centroid
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of each surface rendered object remained consistent throughout the 2h of imaging, we
were able to quantify differences in growth in all three spatial dimensions over time, in
terms of both volume and area of the surface-rendered objects (Figure 3.10 A-F). In all
three dimensions, both surface area and volume of the detected objects were reduced over
the 2h time period, which indicates that growth of hyphae over time is not occurring in
the PPE-DABCO treated yeast that are exposed to the 405nm laser every 5 minutes for
2h. In contrast, untreated cultures of C.albicans showed an increase in both area and
volume of surface-rendered objects over a 1h growth period at 37C, during a live cell
confocal experiment (Figure B2). The effect of photoactivation of PPE-DABCO on cell
growth is quantifiable within 20 minutes of intermittent exposure to light irradiation,
which suggests that the effect leading to an inhibition of hyphal development occurs
rapidly upon activation of PPE-DABCO. We also grew untreated control samples
concurrently and imaged the untreated and PPE-DABCO treated samples initially and
after 2h of growth. As shown in Figure 3.11, the untreated control samples increased in
the total area and volume of surface-rendered objects over the two hour growth period.
The samples treated with PPE-DABCO and exposed to the 405nm laser decreased in total
area and volume over the same time period. Images at 2h were taken of another field of
the PPE-DABCO treated sample that was unexposed to the 405nm laser in two of three
experiments; hyphae grew effectively in PPE-DABCO treated cultures unexposed to the
405nm laser (Figure A.5). The reduction in area and volume of cultures exposed to
photoactivated PPE-DABCO indicates that the cells may be undergoing form of cell
death, although the mechanism by which this is occurring needs to be further elucidated.
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Figure 3.6 Image analysis of PPE-DABCO
live-cell confocal experiments. A) Original
image, green fluorescence from fluorescein
surrounds C. albicans yeast, generating a
negative image. B) Inverted image of A). C)
Areas of cellularity defined as 255, blank
space defined as 0 for quantification of
images. Image analysis performed using
ImageJ (1.48p, Java 1.7.0_07 (64-bit), NIH).
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Figure 3.7 Imaris 4D surface rendering of C.albicans cultures treated with PPE-DABCO and
continuously imaged with 405nm laser. A) Initial image and B) Image following 2h of growth.
Experiment performed in triplicate.
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Figure 3.8 Centroid position of Imaris surface-rendered objects can be tracked over time. A) Scatterplot of
X position (um) of identified surface rendered objects over time (min) B) Scatterplot of Y position (um) of
identified surface rendered objects over time (min). Representative of a single experiment.
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Figure 3.9 Live-cell imaging and activation of PPE-DABCO with the 405nm confocal laser
allows spatial and temporal analysis of C. albicans hyphal growth. A) Area (µm^2) and B)
Volume (µm^3) vs. centroid position of surface rendered object over time (min) of a single
experiment.
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Figure 3.10 Live-cell imaging and activation of PPE-DABCO with the 405nm confocal laser
allows spatial and temporal analysis of C. albicans hyphal growth. A) Area (µm^2) and B) Volume
(µm^3) of surface-rendered cells vs. X position (µm) over time (min). C) Area (µm^2) and D)
Volume (µm^3) of surface-rendered cells vs. Y position (µm) over time (min). E) Area (µm^2) and
F) Volume (µm^3) of surface-rendered cells vs. Z position (µm) over time (min).
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Figure 3.11 Quantification of initial and final area and volume of untreated and PPE-DABCO growth.
Quantification of (A) untreated controls grown without 405nm laser activation concurrently and (B) PPEDABCO (20µg/mL) activated with the 405nm laser every 5 minutes for 2h. Figure shows area (µm2) and
volume (µm3) of Imaris surface rendered objects initially and after 2h of growth at 37C. Data representative
of 3 independent experiments. Untreated controls were from the same C. albicans culture as the PPEDABCO treated cells, and plated on the same an Ibidi µ-slide VI0.4 luer in separate channels. Growth and
imaging of untreated controls performed concurrently to the treated samples.
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3.4 Effect of PPE-DABCO on hyphal growth is distinct from phototoxicity effects
While the previous experiments provided evidence that activation of PPEDABCO using the 405nm confocal laser could inhibit hyphal growth, it remained unclear
if the effect was due to activation of the compound or phototoxicity effects of irradiating
the C. albicans cultures with a high energy light source. A control experiment to assess
phototoxicity of irradiation every 5 minutes for 2h using the 405nm confocal laser
revealed that an untreated C. albicans culture imaged under the same conditions also
showed evidence of inhibited hyphal growth, compared to a control culture which was
unexposed to the 405nm laser (Figure 3.12).

A

B

C

D

Figure 3.12 Exposure every 5 minutes for 2h to 405nm confocal laser inhibits hyphal growth in
untreated C. albicans cultures. A) Initial DIC image of untreated culture exposed to 405nm confocal
laser and B) DIC image after 2h of growth with 405nm laser. C) Initial DIC image of untreated culture
grown in dark conditions D) DIC image after 2h of growth under dark conditions.
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Therefore, in an attempt to isolate the specific effect of PPE-DABCO activation
from the phototoxicity effects of the laser we undertook a series of experiments in which
a single field of a PPE-DABCO treated culture and an untreated culture of C. albicans
was irradiated with the 405nm laser for a 20 minute period. The rationale for the 20
minute exposure time to the 405nm laser was based on our previous time course data that
suggested that the effects leading to hyphal development inhibition may occur within this
time frame. Images of each were taken every five minutes during this period. Following
this pretreatment, the 405nm laser was disengaged and these two fields, along with a field
of a PPE-DABCO treated culture and untreated culture, continued to be imaged for 2h of
hyphal growth, with images taken every 10 minutes during this period. The fluorescein
included in the culture was excluded by the cells, generating a negative image of the cells
that was used to quantify the data using ImageJ (1.48p, Java 1.7.0_07 (64-bit), NIH).
(Figure 3.6). Both the untreated cultures as well as those treated with 20ug/mL PPEDABCO that were unexposed to the 405nm light prior to the 2h of recorded growth
displayed similar growth patterns (Figure 3.13). A slight phototoxicity effect of preexposure to the 405nm laser on the untreated culture is evidenced by a delay in hyphal
growth rate (Figure 3.13 A and C), but the phototoxicity effect alone did not completely
inhibit hyphal development. Strikingly, the 20 minute pre-exposure to the 405nm laser
caused a drastic inhibition of hyphal growth of C. albicans cultures treated with PPEDABCO, with little to no detectable hyphal growth in the 2h following light-irradiation
(Figure 3.13 A and E). Furthermore, reductions in total area cellularity of the light
exposed PPE-DABCO treated cultures over this period of time suggests that some form
of cell death may be occurring, although this observation needs to be further explored for
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validity. The results of these experiments provide strong evidence that PPE-DABCO
treatment alone cannot significantly hinder hyphal development in C. albicans.
Additionally, while there are observable phototoxicity effects of untreated cultures due to
exposure to the 405nm confocal laser, these effects alone cannot account for the complete
inhibition of hyphal development. This indicates that light activation of PPE-DABCO is
the primary cause for the inability of C. albicans yeast to undergo the transition to hyphal
morphology under these particular growth conditions. The mechanism by which this may
be occurring remains to be elucidated with further studies.
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Figure 3.13 Activation of PPE-DABCO with 405nm confocal laser for 20 minutes is effective at
inhibiting hyphal growth in C. albicans. C. albicans cultures were treated with or without
20µg/mL PPE-DABCO, then exposed intermittently to a 405nm confocal laser for 20 minutes.
Following exposure, cultures were induced to grow hyphae for 2h without exposure to the 405nm
laser. Untreated and PPE-DABCO treated controls that did not receive any exposure to the
405nm laser were included for comparison. A) Scatterplot of normalized total area cellularity
(per imaged field) vs. time (min) of each of the four conditions. (B-E) Boxplots representing the
normalized change in total area cellularity (per imaged field) over time. Graphs are representative
of compiled data from three independent experiments.
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3.5 Effect of PPE-DABCO on viability following 405nm confocal laser exposure
The inhibition of hyphal growth in cultures exposed to the 405nm confocal laser
during PPE-DABCO treatment, as well as the appearance of probable cell debris in the
confocal images over time, illustrated the possibility that photoactivation of the agent
with the 405nm laser may lead to cell death. To assess the effect of 405nm
photoactivation of the compound on the viability of C.albicans, we performed a live-cell
7-AAD viability assay following a 30 minute pretreatment with PPE-DABCO and a
thorough washing of the cells to remove the excess agent. We scanned a single field of an
untreated culture and a PPE-DABCO treated culture using the 405nm laser every 8
minutes, for a total of 8 scans apiece. We then stained the cells with calcofluor-white and
imaged the fields again, along with a single field each of the untreated and PPE-DABCO
treated cultures which were not previously exposed to the 405nm laser. We saw a
significant reduction in the viability of the fields treated with PPE-DABCO and photoactivated with the 405nm laser (Figures 3.14 and 3.15). Furthermore, due to the washing
of the cells, this reduction in viability cannot be attributed to the singlet oxygen
generation resulting from photo-activation of free agent in solution, but by the activation
of PPE-DABCO in direct contact with the cell. We saw a reduction in viability in fields
that were treated with PPE-DABCO but that were unexposed to the 405nm laser, but this
reduction was not found to be significant. The effect of the 405nm laser on the viability
of the untreated culture was minimal and not significant; indicating that phototoxicity
alone cannot explain the reduction in viability seen in the photoactivated PPE-DABCO
treated cultures.
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Figure 3.14 Confocal images of C. albicans viability test with 7-AAD. (A-C) Untreated dark
culture. (D-F) Untreated culture exposed to 405nm confocal laser for 60min. (G-I) PPEDABCO (20ug/mL) treated dark culture. (J-L) PPE-DABCO (20ug/mL) treated culture
exposed to 405nm confocal laser for 60min. Images analyzed using ImageJ (1.48p, Java
1.7.0_07 (64-bit), NIH).
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Figure 3.15. C. albicans viability test with 7-AAD. Quantification of images represented in
Figure 3.11. Experiment performed in triplicate; three fields per sample per experiment were
quantified. Images analyzed using ImageJ (1.48p, Java 1.7.0_07 (64-bit), NIH). Statistical
significance assessed via a 2-sample, unequal variance T-test. Star indicates p-value<0.05.

3.6 Effect of PPE-DABCO and EO-DABCO on yeast to hyphal transition in
surviving cells
While the antifungal effects of both compounds were evidenced by CFU
reduction following light irradiation, we wanted to assess whether exposure to the agents
and subsequent photoactivation results in a heritable loss of ability to make hyphae in the
cells that are not acutely killed and then allowed to produce many generations of
progeny. The yeast to hyphal transition is an essential component of the development of
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C. albicans biofilms. To test whether treatment with 20ug/mL PPE-DABCO or EODABCO, followed by light irradiation of the cultures for 60 minutes, could inhibit this
transition in surviving cells, or cause an observable morphological change in hyphal
structure, dilutions of exposed cultures, including untreated controls, were plated on YPD
agar plates and incubated at 37C for four days, then representative samples of each
culture were incubated either at room temperature for 1h in the dark, or at 37C for 3h or
24h in the dark to induce hyphal growth and immediately imaged on the laser-scanning
confocal microscope. All samples were able to grow hyphae after 3h incubation at 37C,
indicating that neither exposure to light irradiation alone, nor light activation of the
biocidal compounds, was sufficient to inhibit the yeast to hyphal transition (Figure 3.16).
In addition, all samples were able to effectively grow dense biofilm structures
after 24h of exposure to hyphal growth inducing conditions (Figure 3.17), with no readily
observable impediment to the biofilm development due to either exposure to 60 min light
irradiation alone, or light activation of the compounds used to treat the original cultures.
From this result, we were able to conclude that light-irradiation, with or without
application of PPE-DABCO or EO-DABCO, of C.albicans suspension cultures did not
result in inhibition of the yeast to undergo transition to hyphal form or the development
of dense biofilm structures.
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Figure 3.16 60 minutes of light-activation of PPE-DABCO and EO-DABCO is insufficient at
preventing the yeast to hyphal transition in surviving cells. A) DIC image of an untreated culture after
1h incubation at 25C following exposure to 60 min UV-irradiation and B) after 3h of growth at 37C.
C) DIC image of an untreated culture after 1h incubation at 25C following exposure to 420nm light
for 60 min and D) after 3h of growth at 37C. (E-H) Culture treated with EO-DABCO (20µg/mL) and
exposed to 60min UV-irradiation. E) EO-DABCO signal of culture after incubation for 1h at 25C and
F) merged with DIC image. G) EO-DABCO signal of culture after incubation for 3h at 37C and H)
merged with DIC image. (I-L) Culture treated with PPE-DABCO (20µg/mL) and exposed to 60min
420nm-irradiation. I) PPE-DABCO signal of culture after incubation for 1h at 25C and J) merged with
DIC image. K) PPE-DABCO signal of culture after incubation for 3h at 37C and L) merged with DIC
image.
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Figure 3.17. Light-irradiation alone, or with application of PPE-DABCO or EO-DABCO, is
not sufficient to impede C. albicans biofilm development. C. albicans 24h biofilms were
grown from suspension cultures exposed to 60min of light-irradiation. A) 24h biofilms grown
from a 60 minute UV-irradiated untreated culture or B) a culture treated with 20µg/mL EODABCO and exposed to UV-irradiation for 60 minutes. C) 24h biofilms grown from an
untreated culture exposed to 420nm light for 60 minutes or D) a culture treated with 20µg/mL
PPE-DABCO and exposed to 420nm light for 60 minutes. E) A 24h biofilm grown from a
scraping from the original C. albicans stock culture and unexposed to light irradiation.
Images are Z-projections of 3D image stacks based on max intensity of CFW staining using
ImageJ (1.48p, Java 1.7.0_07 (64-bit), NIH).
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3.7 Effect of PPE-DABCO and EO-DABCO on C. albicans biofilm formation
After concluding that neither the yeast to hyphal transition nor the development of
biofilm structure could not be fully impeded by light irradiation of either PPE-DABCO or
EO-DABCO, we next decided to ascertain whether C. albicans treated with these
compounds, in the dark or following 30 minutes light irradiation, could form biofilms
with similar structural characteristics as untreated C. albicans biofilms. Biofilms were
grown out to 25h from suspension cultures diluted to 1e6 cells/mL following treatment,
stained the biofilms with calcofluor-white, and immediately imaged on the laser-scanning
confocal microscope. To assess overall structural characteristics of the biofilms, we
analyzed the distribution of the average cellularity of the biofilms as a function of Zdepth, which gave an estimation of the average thickness of the entire biofilm structure,
as well as an estimation of cellular density at different depths of the structure (Figure
3.18). The untreated cultures unexposed to light irradiation showed a broader distribution
of the cellular mass of the biofilm structure over a Z-thickness that ranged over 40um
(Figure 3.18 A). The biofilms grown from cultures that were treated with 20ug/mL of
either EO-DABCO or PPE-DABCO in the dark, had distributions of cellularity that were
less broadly distributed than the untreated biofilm, with most of the cellular bulk of these
biofilms ranging over a Z-thickness of roughly 35um. Interestingly, the biofilms grown
from cultures treated with PPE-DABCO in the dark displayed a greater average percent
area cellularity over a similar Z-thickness range as the untreated and EO-DABCO from
cultures kept in the dark, which may indicate that treatment with PPE-DABCO may lead
to the production of biofilms with a greater cellular density. All of the biofilms grown
from cultures irradiated for 30 minutes with either 420nm or UVA light, with or without
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the presence of PPE-DABCO or EO-DABCO, displayed a sharp peak of increased
average percent area cellularity over a Z-thickness ranging from approximately 15-20um,
compared to the biofilms grown from the untreated cultures that were kept in the dark.
The mechanism governing this observation is unclear, but may represent a cellular
response to stressful environmental conditions, either the presence of the compounds,
light-irradiation, or a combined effect of both. To further analyze differences in biofilm
structures between the samples, we next looked at the distribution of average percent area
cellularity per 2um Z-slice (Figure 3.18 B). Notably, the biofilms grown from cultures
that were treated with PPE-DABCO and exposed to 30 minutes UV-irradiation displayed
a significant increase in the median average percent area cellularity per 2um Z-slice
(Figure 3.18 C), while the median average percent area cellularity values for all other
conditions were not significantly different from the untreated controls grown from
cultures kept in the dark. To further examine differences in the distribution of average
cellularity of the analyzed biofilms, we generated a density histogram of the average
percent area cellularity per 2um Z-slice (Figure 3.18 D). The untreated dark biofilms
displayed a mean of 4.339 average percent area cellularity per Z-slice. This value was
similar to the means observed for the biofilms grown from cultures treated with EODABCO, both in dark conditions and following 30 minutes UV-irradiation, and biofilms
grown from cultures treated with PPE-DABCO following light irradiation at 420nm, with
the mean values ranging from 4.311 to 4.977. Notably, the biofilms grown from cultures
treated with PPE-DABCO in the dark displayed a much higher observed mean of the
average percent area cellularity per Z-slice than the untreated dark biofilms, 10.19. This
also supports previous evidence that treatment with 20ug/mL PPE-DABCO in the

64

absence of light irradiation may lead to the development of a more densely packed
biofilm structure. Surprisingly, it was observed that biofilms grown from untreated
cultures that were irradiated with 420nm or UV-light also displayed a higher mean than
the untreated dark biofilms, with values of 6.890 and 5.788, respectively. This may
indicate that light irradiation alone may have some effect on the development of biofilm
structure as well, although further testing and analysis need to be performed to confirm
this observation.
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Figure 3.18. Growth of 25h biofilms from C. albicans cultures. C. albicans cultures were treated
with PPE-DABCO (20ug/mL) or EO-DABCO (20ug/mL) for 2h in the dark or 30 minutes
irradiation with 420nm-light or UV-light (to activate PPE-DABCO or EO-DABCO respectively).
Untreated controls were also exposed to 30 minutes irradiation with 420nm-light or UV-light.
Biofilms were stained with 20ug/mL calcofluor-white and imaged at 25h. A) Distribution of the
average cellular density of biofilms is represented by plotting the average percent area cellularity
of three fields per biofilm, three biofilms per condition vs. Z depth (um). B) Boxplot representing
the distributions of average percent area cellularity per 2um Z-slice of data from (A). The symbol
represents statistical significance in a CI of 95.0%, as determined by Mann-Whitney
nonparametric comparison of medians. C) Table of median average percent area cellularity per
2um Z-slice, quantified from data represented in (B). Data representative of the average of 3 fields
per biofilm, 3 biofilms per condition.
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Chapter 4. Conclusion
In this study, we determined that the light activation of PPE-DABCO and EODABCO could efficiently kill C. albicans planktonic cells in suspension. Furthermore,
we were able to visualize and photoactivate the agents with a 405nm confocal laser,
which allowed us to quantify time-dependent changes in the cells in response to the
treatment. Furthermore, by washing out the excess PPE-DABCO in our viability assays,
as well as our live-cell experiments, we were able to determine that the direct physical
interaction of the agent with the cell was responsible for the antimicrobial effect, and not
the result of singlet oxygen generation by activation of the free compound in solution.
However, this study did not elucidate the extent to which the compounds are able to
penetrate the cell wall of the yeast. It remains to be investigated whether the compounds
are able to interact with the cell membrane of yeast and hyphal cells. Previous work has
demonstrated that CPEs, particularly PPE-Th, another cationic conjugated polyelectrolyte
with similar biocidal properties as the agents used in this and previous antifungal studies,
possesses the ability to induce remodeling of the outer membrane of bacteria, as well as
the peptidoglycan layer prior to causing the cytoplasmic membrane to collapse, killing
the cell (119, 122). We did see a reduction in viability of C. albicans yeast with PPEDABCO in the dark, but the mechanism by which this is occurring remains to be
elucidated. It is possible that insertion of these compounds into the cell wall or cell
membrane can induce remodeling of these features by activating cell wall stress response
pathways or other mechanisms. The ability of C. albicans to remodel the cell wall in
response to drug treatment has been well documented; low levels of treatment with
echinocandins have been demonstrated to induce the synthesis of chitin, leading to an
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increase of chitin in the cell wall and conferring a protective effect to the cell (123, 55).
Furthermore, cell wall remodeling has also been observed with other compounds that
interact directly with the cell wall, including calcofluor-white and Congo red by
activating the HOG MAP kinase pathway in S. cerevisiae (124). If cell wall remodeling is
occurring, it remains to be determined which cell wall remodeling pathway is activated,
what implications this dynamic response may hold with regards to virulence of the
surviving cells.
We demonstrated that single cell hyphal growth stops upon treatment with PPEDABCO and photoactivation of the agent. While there was an inhibition of hyphal
growth with photoactivation of the compounds, it is unclear to what extent this is due to
the increase in cell death that occurs with photoactivation of PPE-DABCO. Preliminary
experiments demonstrated that both compounds inhibited the development of hyphae
after 2 hours of continuous activation using the 405nm laser. What appeared to be cell
debris was visible in images of cultures treated with PPE-DABCO and irradiated every 5
minutes for 2 hours with the 405nm laser. However, cultures that were treated with the
agents and exposed to light for 60 minutes in the photochamber were still able to produce
surviving cells that effectively form hyphae. It remains to be elucidated the relative
contribution of both the source of the irradiation (i.e. laser vs. lamp) and the time of light
exposure to inhibiting this morphological transition.
The necessity of light activation of these compounds to both kill planktonic cells
and inhibit the yeast to hyphal transition indicates that the induction of singlet oxygen is
critical for full efficacy of the agents. However, the mechanism by which cell death may
be occurring, the relative ability of individual compounds to interact with the cells and
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generate singlet oxygen, and the contribution of the geometry and structure of the
biocidal compounds to the ability of the agents to interact with and kill the cells remains
to be investigated.
Our live cell experiments in which we activated PPE-DABCO with the 405nm
confocal laser allowed us to not only visualize the effects to individual cells in response
to treatment over time, it also enabled us to quantify the morphological cellular changes,
and in so doing, assess the time-dependency of the cellular responses. However, this
study failed to sufficiently elucidate the specific mechanistic effects of 405nm irradiation
alone and the contribution of activation of PPE-DABCO to causing cellular damage. The
detrimental effects of UV-light on C. albicans has been observed, both in experiments
performed by our laboratory as well as others. A recent study by Risovic et al. provided
evidence that the efficiency of using UV and visible light to eradicate C. albicans was
wavelength dependent, with the strongest effect observed using light centered at 406nm
(126). As our live-cell confocal experiments utilized the 405nm laser at a relatively high
power, phototoxicity effects on untreated cultures became a confounding factor in
analysis. Although we were able to provide evidence that the effects of PPE-DABCO
activation could be isolated from phototoxicity effects, by limiting the time the cultures
were irradiated with the 405nm laser to 20min, it remains unclear how the 405nm laser is
affecting the cellular processes of the untreated and treated cells. A study by Farrell et al.
demonstrated that low-level UV-pulsed light irradiation of clinical strains of C. albicans
resulted in enhanced membrane permeability and an increase in the ROS localized to the
mitochondria. The increase in intracellular ROS production resulted in a concurrent
increase in apoptotic markers, including the abnormal condensation of chromatin and
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exposure of phophatidylserine on the outer portion of the cell membrane. Increasing the
UV dosage resulted in nuclear damage, activation of cellular repair mechanisms,
irreversible cell membrane leakage, and an increase in apoptotic and necrotic cells (127).
This indicates that even in our experiments in which the time of exposure to the 405nm
laser was limited, it is likely that reversible and irreversible effects to the cells may be
occurring, even in the absence of the photoactivating agent. Furthermore, it remains to be
investigated whether the phototoxicity effects of 405nm light on EO-DABCO treated
samples can be isolated from the effects of photoactivation of the compound. The timedependent responses of EO-DABCO treated cultures, both irradiated and without
photoactivation, needs to be assessed, perhaps in another set of live-cell imaging
experiments.
Cultures that were previously exposed to PPE-DABCO and EO-DABCO and
irradiated with light were still able to form biofilms subsequently, as were cultures that
were irradiated with UV-visible light alone and cultures that were treated with the agents
in the absence of photoactivation of the compounds. We observed quantifiable changes in
the overall structural characteristics of biofilms exposed to PPE-DABCO in the dark, and
among the biofilms exposed to light-irradiation. However, the implications of these
observations remain unclear. Further characterization of biofilms grown under these
conditions is necessary to fully elucidate any mechanistic and structural changes in the
biofilm growth, which may affect the ability of small molecules to diffuse through the
structure, the overall resistance of different biofilm structures to antifungal therapy, and
the composition of both the cell wall of cells within the biofilms and the ECM.
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One of the considerations for antimicrobial efficiency of agents is the ability to
effectively penetrate and kill cells within a biofilm. Previous work by Dascier et al.
demonstrated EO-OPE compounds with 1,4-diazabicyclo[2,2,2]-octane (DABCO) groups
demonstrated greater efficiency at eradicating E. coli bacterial biofilms than EO-OPE
compounds containing traditional quarternary ammonium side chains, which is thought to
be related to the ability of the EO-DABCO compounds to more easily penetrate the
biofilm structure. This study also demonstrated that the relative amount of singlet oxygen
generation does not directly correlate to the effectiveness of the biocidal activity against
biofilms, which may indicate that geometry of the compound influences the killing ability
in addition to the efficiency of singlet oxygen generation (128). While the results of our
study demonstrated the ability of these compounds to inhibit the yeast to hyphal
transition, which is important for the attenuating the pathogenicity of C. albicans, we
have not yet investigated the ability of PPE-DABCO and EO-DABCO to effectively
penetrate and eradicate mature biofilms. It is possible that the antimicrobial ability of
these compounds will be attenuated in a biofilm environment, where the presence of
copious amounts of heterogeneous ECM may bind the compounds nonspecifically and
inhibit diffusion. This may be influenced by the structure and physical properties of the
agents, and it needs to be determined whether the molecular weight, geometry and
charges of the compounds affect the activity against mature biofilms. For example, a
study conducted by Ji et al. demonstrated that the increasing length of the chain of CPE
compounds correlated to a reduction of effectiveness against bacteria; the relative chain
length of polymerized compounds may affect the ability of the agent to diffuse through a
biofilm structure (129). Furthermore, it has been demonstrated that 10-30 times the
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concentration of EO-OPEs was required to show effectiveness against E.coli biofilms,
which indicates that increasing the concentration of these agents when treating C.
albicans biofilms may be necessary for full eradication (128). It has been previously
demonstrated that UV-light irradiation increases the effectiveness EO-OPEs against E.
coli biofilms (128). The efficiency of the compounds against C. albicans biofilms in both
the light and dark needs to be assessed; the relative amount of biofilm eradication may be
vastly different between the two conditions. This may aid in elucidating the mechanisms
of the antimicrobial activities of the compounds against mature biofilms.
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Appendix A. Supplemental Figures and Methods
A. Supplemental Methods
A.1. Limiting dilution assay
C. albicans 5314 were grown overnight (16-18h) in 5mL YPD broth (scraping
taken from LiN2 ATCC stock) at 30C in the orbital shaker, 300rpm. For light exposure
experiments, yeast suspension (1e6 cell/mL in PBS) were transferred to VWR Glass
Vials, Short Form Style, Phenolic Cap on, 0.5 Dr. For dark experiments, , yeast
suspension (1e6 cell/mL in PBS) were transferred to 1.5uL polypropylene centrifuge
tubes. PPE-DABCO was added to a final concentration of 20µg/mL to cultures
suspended in PBS at 1e6 cells/mL. Cultures were incubated with PPE-DABCO for 30
minutes prior to washing 3 times in PBS by centrifugation at 10,000xg for 5 minutes,
followed by siphoning off the supernatant and resuspending cells in PBS, at 1e6cells/mL.
Untreated controls included for both dark and light exposure experiments. The light
irradiation experiments were carried out in a photoreactor (4 UV-lamps, LZC-ORG,
Luzchem Research Inc., Ottawa, Canada). LZC-420 (centered at ~420 nm) was used to
activate PPE-DABCO treated cultures and untreated cultures for 30min at room
temperature. For dark exposure experiments, yeast were incubated, following
pretreatment with PPE-DABCO and washing, for 30 minutes at room temperature in the
dark. Following the 30 minute incubation in the dark or in the photochamber, the samples
at 1e6cells/mL were diluted to the following ratios: undiluted (1:1e6), 1:1e3, 1:1e5,
1:1e6, 1:1e7. 1 µL of each sample, including the original undiluted sample was plated in
triplicate on YPD agar plates, which were incubated for four days at 30C. Digital
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photographs were taken periodically and analyzed in ImageJ (1.48p, Java 1.7.0_07 (64bit), NIH).
A.2 FUN1 Metabolic Assay
C. albicans 5314 were grown overnight (16-18h) in 5mL YPD broth (scraping
taken from LiN2 ATCC stock) at 30C in the orbital shaker, 300rpm. Yeast suspension
(1e6 cell/mL in PBS) were transferred to 1.5uL polypropylene centrifuge tubes. PPEDABCO was added to a final concentration of 20µg/mL to cultures suspended in PBS at
1e6 cells/mL. Cultures were incubated with PPE-DABCO or left untreated for 30 minutes
prior to washing 3 times in PBS by centrifugation at 10,000xg for 5 minutes, followed by
siphoning off the supernatant and resuspending cells in in RPMI+300mg/L Lglutamine+0.165M MOPS+0.2% glucose (pH 7.4) containing 20uM fluorescein at 1e6
yeast/mL. FUN1 was added to a final concentration of 10uM. 150µL of yeast were added
to each of two channels, one containing the untreated suspension and the other channel
containing the PPE-DABCO treated yeast, of an Ibidi µ-slide VI0.4 luer (80601) using a
pipette. The slide was incubated at 30C for 1h to allow yeast to adhere. a single field of
the PPE-DABCO culture and untreated culture were exposed to the 405nm laser (14%,
HV 830V, Gain 1) to activate the PPE-DABCO for a total of 4 scans per field
(1024x1024, 0.207µm/pixel, Z depth 20 slices, 1.5µm/slice, scanning speed 2.0µs/pixel).
The cultures were simultaneously scanned with the 473nm laser to fluoresce the
fluorescein. Following this scan, the 405nm laser was shut off, and the PPE-DABCO and
untreated fields previously exposed to the 405nm laser, along with a PPE-DABCO and
untreated field not previously exposed to the 405nm laser, continued to be scanned for a
following 2h, Z-stacks of each field taken every 10min (PLAPON 60X O NA:1.42,
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0.207µm/pixel x 0.207µm/pixel, Z depth 20 slices, 1.5µm/slice, Sampling speed
2.0µs/pixel). The 473nm laser was used to visualize the fluorescein to generate a negative
image of the growing cells that was used for image processing (1%, HV 610V, Gain 1).
Experiment was performed once. Analysis of images was performed in ImageJ (1.48p,
Java 1.7.0_07 (64-bit), NIH).
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1 day incubation

3 days incubation

Figure A.1. Limiting dilution assay. C.albicans colonies on YPD agar following one or three
days incubation at 30C. A-B) Untreated dark culture. C-D) Untreated culture exposed to
420nm light-irradiation for 30 minutes. E-F) PPE-DABCO dark treated culture. G-H) PPEDABCO treated culture following 420nm light-irradiation for 30 minutes. Experiment
performed in triplicate. Images representative of a single experimental repeat.
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2 days incubation

4 days incubation

Figure A.2. Limiting dilution assay. C.albicans colonies on YPD agar following two or four
days incubation at 30C. A-B) Untreated dark culture. C-D) Untreated culture exposed to
420nm light-irradiation for 30 minutes. E-F) PPE-DABCO dark treated culture. G-H) PPEDABCO treated culture following 420nm light-irradiation for 30 minutes. Experiment
performed in triplicate. Images representative of a single experimental repeat.
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3 days incubation

5 days incubation

Figure A.3. Limiting dilution assay. C.albicans colonies on YPD agar following three or five
days incubation at 30C. A-B) Untreated dark culture. C-D) Untreated culture exposed to
420nm light-irradiation for 30 minutes. E-F) PPE-DABCO dark treated culture. G-H) PPEDABCO treated culture following 420nm light-irradiation for 30 minutes. Experiment
performed in triplicate. Images representative of a single experimental repeat.
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Figre A.4. FUN1 was added to C.albicans cultures (1e6 cells/mL) at a final concentration of 10µM.
Quantification performed after two hours of growth following the 20 minute pre-exposure of the
untreated and PPE-DABCO treated field to the 405nm laser. Experiment was performed once.
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Figure A.5. Imaris surface rendering of C.albicans hyphal growth from live-cell confocal
experiments with 405nm laser. A) Untreated culture after 2h of growth without 405nm
laser activation. B) PPE-DABCO (20ug/mL) treated culture after 2h of growth without
405nm laser exposure. Experiment performed in duplicate. Images representative of a
single experimental repeat.
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Appendix B. C. albicans growth under flow
B. Supplemental Methods
B.1. Growth of C. albicans biofilms under flow conditions
C. albicans 5314 were grown under flow conditions using either an Ibidi µ-slide I
0.2

Luer uncoated (80161), channel height 200 µm, 50 µL volume or an Ibidi µ-slide I 0.8

Luer uncoated (80191), channel height 800 µm, 200 µL volume. The slide was first
prepared the day prior to live imaging by attaching 2 dams constructed from two 15mL
polypropylene tubes, which were cut at the 14mL mark with a narrow notch cut into the
dams from the top to the middle (about 2-3mm wide). The dams were positioned around
the inlet and outlet of the slide, with both notches positioned in the same direction 90
degrees perpendicular to the narrow side of the slide; the notches hold the vacuum lines
in place as a precaution against leakage overflow of media. The dams were attached to
the slide using DAP® brand 100% Silicone All-Purpose Adhesive Sealant to prevent
leakage of media during media flow through the slide. The slide was then filled with
sterile fetal bovine serum with two 1mL syringes, leaving the syringes in the inlet and
outlet after injection. The slide was incubated overnight at room temperature and handled
exclusively in the BSC. C. albicans 5314 were grown overnight (16-18h) in 5mL YPD
broth (scraping taken from LiN2 ATCC stock) at 30C in the orbital shaker, 300rpm. The
following day, the media, pump and all components of the microfluidics were preheated
on the microscope stage, set to 37C. The slide was washed with 5mL of PBS, using two
5mL syringes in the inlet and outlet. The yeast were counted with a hemocytometer and
1.0-1.5e6 yeast were washed in 1mL PBS one time at 10,000xg for 5min. The pellet was
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resuspended in 1mL RPMI+300mg/L L-glutamine+0.165M MOPS+0.2% glucose (pH
7.4). The yeast were added to the slide using two 1mL syringes and allowed to adhere by
incubation the slide at 37C for 1h. For biofilms grown with 0.1ug/mL calcofluor white,
calcofluor white was added to warmed RPMI media at a final concentration of 0.1ug/mL.
For biofilms grown in fluorescein, fluorescein was added to warmed RPMI media at a
final concentration of 10uM. For biofilms grown in caspofungin, casofungin was added
to the warmed RPMI media at final concentrations of 0.015ug/mL. The media was flown
through the slide at a rate of 0.1mL/min using a Watson Marlow 120 pump. The confocal
stage was kept at 37C for the duration of imaging. The imaging was performed using an
Olympus FV1000 confocal microscope (PLAPON 60X O NA:1.42, 0.207um/pixel x
0.207um/pixel x 2.0um/slice, Sampling speed 2.0us/pixel), with Z stacks imaged every 5
min. Analysis performed using Imaris software (X63, 6.1.5, Bitplane, Zurich,
Switzerland), Minitab® (16.2.4, LEADTOOLS © 1991-2004, LEAD Technologies, Inc.)
and Microsoft® Excel® 2010 (14.0. 7109.5000).
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Figure B1. C.albicans growth over time under flow. Imaris surface-rendered objects from a
single experimental repeat of a flow experiment performed with fluorescein and
2
calcofluor-white. Objects with an initial area greater than 500µm were excluded from
further analysis, based upon the position of the centroid of the object. Each time point
equals 5 minutes.
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Figure B2. Live-cell imaging and activation of untreated C. albicans culture with fluorescein
allows spatial and temporal analysis of hyphal growth. A) Area (µm ^2) and B) Volume (µm^3)
of surface-rendered cells vs. X position (µm) over time (min). C) Area (µm ^2) and D) Volume
(µm^3) of surface-rendered cells vs. Y position (µm) over time (min). E) Area (µm^2) and F)
Volume (µm^3) of surface-rendered cells vs. Z position (µm) over time (min). Experiment
performed in triplicate. Graphs representative of a single experimental repeat.

95

Figure B3. C.albicans growth over time under flow. Imaris surface-rendered objects from a single
experimental repeat of a flow experiment performed with fluorescein and calcofluor-white.
2
Objects with an initial area greater than 500µm were excluded from further analysis, based
upon the position of the centroid of the object. Graphical example of tracked surface-rendered
2
objects change in area (µm ) over time. Each time point equals 5 minutes.
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Figure B4. C.albicans radius of curvature of hyphae following 2h of growth under flow. Imaris
surface-rendered objects from a single experimental repeat of a flow experiment performed with
fluorescein only. Radius of curvature determined using three points along the entire length of the
surface-rendered object. Calculation of radius of curvature performed using Excel formula from
Newton Excel Bach: ArcCenP3.
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Appendix C. C. albicans growth with sub-MIC caspofungin
C. Supplemental Methods
C.1. C. albicans dosage response to caspofungin under static conditions
C. albicans 5314 were grown overnight (16-18h) in 5mL YPD broth (scraping taken from
LiN2 ATCC stock) at 30C in the orbital shaker, 300rpm. The yeast were counted with a
hemocytometer, and washed in 1mL PBS one time at 10,000xg for 5min. Approximately
4e5 yeast/mL were resuspended RPMI+300mg/L L-glutamine+0.165M MOPS+0.2%
glucose (pH 7.4). Yeast were seeded on MatTek Glass Bottom 35mm Microwell Dish,
No. 1.5 coverglass (0.16-0.19mm), by adding 2mL of the yeast suspension to each dish.
Caspofungin was added in the following concentrations to individual dishes: 0, 0.02, 0.03
and 0.04ug/mL. The dishes were incubated at 37C, 5% CO2 for 1h. The cells were then
fixed by addition of 4% PFA for 20min at room temperature. The dishes were washed
three times in PBS to remove non-adherent cells and excess PFA by rinsing with PBS
and using vacuum suction. Following washing, 2mL of PBS was added to each dish and
remaining cells were stained with calcofluor-white at a final concentration of 10ug/mL.
The yeast were immediately imaged on an Olympus FV1000 confocal microscope
(UPLSAPO 40X 2 NA:0.95, 0.31 um/pixel x 0.31 um/pixel x 1.5um/slice, Sampling
speed 2.0us/pixel). Experiment performed in triplicate, 7-10 fields analyzed per dish
using Imaris software (X63, 6.1.5, Bitplane, Zurich, Switzerland) and Minitab® (16.2.4,
LEADTOOLS © 1991-2004, LEAD Technologies, Inc.).
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A

B

C

D

Figure C.1. Quantifiable, dose-dependent changes in the distribution of hyphal elongation in the
2
presence of sub-MIC concentrations of caspofungin. A) Distribution of area (µm ) of hyphae
following 1h of growth with indicated concentrations of caspofungin. B) Kurtosis of (A). C)
3
Distribution of volume (µm ) of hyphae following 1h of growth with indicated concentrations of
caspofungin. D) Kurtosis of (C). Hyphae fixed in 4% PFA following 1h of growth at 37C, stained
with 10µg/mL calcofluor white and imaged with laser-scanning confocal microscopy. Data from
three independent experiments (N=763, 946, 902, 827 individual cells for control, 0.02µg/mL,
0.03µg/mL, 0.04µg/mL caspofungin respectively).
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Figure C.2. Quantifiable, dose-dependent changes in the distribution of hyphal elongation in the
presence of sub-MIC concentrations of caspofungin. Graphical representation of surface

area to volume ratio. Hyphae fixed in 4% PFA following 1h of growth at 37C, stained with
10µg/mL calcofluor white and imaged with laser-scanning confocal microscopy. Data from three
independent experiments (N=763, 946, 902, 827 individual cells for control, 0.02µg/mL,
0.03µg/mL, 0.04µg/mL caspofungin respectively).
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A

B

C

Figure C.3. Morphological differences observable in hyphae in presence of increasing doses of
2
3
-1
caspofungin. A) Area (µm ) B) Volume (µm ) and C) Surface area to volume ratio (µm ) of hyphae
grown for 1h at 37C in presence of indicated concentrations of caspofungin. Hyphae fixed with 4% PFA
for 20 minutes, stained with 10µg/mL calcofluor white and imaged with laser-scanning confocal
microscopy. Data from three independent experiments (N=763, 946, 902, 827 individual cells for
control, 0.02µg/mL, 0.03µg/mL, 0.04µg/mL caspofungin respectively). Statistical significance at 95% CI
determined by Mann-Whitney nonparametric comparison.
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Figure C.4. Chitin content of hyphal cell
wall correlates to an increase in hyphal
volume. A-D) Marginal plots of hyphal
3
volume (µm ) vs. intensity median of
calcofluor-white fluorescence for
populations treated with indicated
concentrations of caspofungin. E)
Regression analysis for data presented in
A-D. Hyphae fixed in 4% PFA following 1h
of growth at 37C, stained with 10µg/mL
calcofluor white and imaged with laserscanning confocal microscopy. Data from
three independent experiments (N=763,
946, 902, 827 individual cells for control,
0.02µg/mL, 0.03µg/mL, 0.04µg/mL
caspofungin respectively) *Outliers
excluded from analysis of D.

102

A

B

A

D

C

A

A

Figure C.5. Increased chitin content of hyphal cell wall correlates to a decrease in SA:Vol ratio of hyphae.
-1
A-D) Marginal plots of hyphal SA:Vol ratios (µm ) vs. intensity median of calcofluor-white fluorescence for
populations treated with indicated concentrations of caspofungin. E) Regression analysis for data
presented in A-D. Hyphae fixed in 4% PFA following 1h of growth at 37C, stained with 10µg/mL calcofluor
white and imaged with laser-scanning confocal microscopy. Data from three independent experiments
(N=763, 946, 902, 827 individual cells for control, 0.02µg/mL, 0.03µg/mL, 0.04µg/mL caspofungin
respectively)
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Regression
Analysis
Condition

Equation

Control

P

R^2

R-Sq(adj)

control (1h) SA/V
ratio = 2.66 - 0.00438
control (1h) intensity
median
0.000

35.6%

35.5%

0.02µg/mL cas (1h)
SA/V ratio = 2.44 0.00374 0.02µg/mL
0.02µg/mL cas cas(1h)intensity med 0.000

16.9%

16.8%

0.03µg/mL cas (1h)
SA/V ratio = 2.90 0.00506 0.03µg/mL
0.03µg/mL cas cas(1h)intensity med 0.000

25.4%

25.3%

0.04µg/mL cas (1h)
SA/V ratio = 3.43 0.00652 0.04µg/mL
0.04µg/mL cas cas(1h)intensity med 0.000

22.9%

22.9%

Figure C.6. Increased chitin content of hyphal cell wall correlates to a decrease in SA:Vol ratio of hyphae.
Regression analysis for data presented in Figure C.5 (A-D). Hyphae fixed in 4% PFA following 1h of growth
at 37C, stained with 10µg/mL calcofluor white and imaged with laser-scanning confocal microscopy. Data
from three independent experiments (N=763, 946, 902, 827 individual cells for control, 0.02µg/mL,
0.03µg/mL, 0.04µg/mL caspofungin respectively)
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